<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/477901</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Physiology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Towards understanding biology of leydiogioma. G protein-coupled receptor and peroxisome proliferator-activated receptor crosstalk regulates lipid metabolism and steroidogenesis in Leydig cell tumors</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Kotula-Balak</surname><given-names>Malgorzata</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">&#x00A7;</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Gorowska-Wojtowicz</surname><given-names>Ewelina</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">&#x00A7;</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Milon</surname><given-names>Agnieszka</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pawlicki</surname><given-names>Piotr</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kaminska</surname><given-names>Alicja</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pardyak</surname><given-names>Laura</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tworzydlo</surname><given-names>Waclaw</given-names></name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>P&#x0142;achno</surname><given-names>Bartosz J.</given-names></name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hejmej</surname><given-names>Anna</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wolski</surname><given-names>Jan K.</given-names></name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Department of Endocrinology, Institute of Zoology and Biomedical Research, Jagiellonian University in Krakow</institution>, Poland, Gronostajowa 9, 30-387 Krakow, <country>Poland</country>.</aff>
<aff id="a2"><label>2</label><institution>Developmental Biology and Invertebrate Morphology, Jagiellonian University</institution> in Krak&#x00F3;w, Poland, Gronostajowa 9, 30-387 Krakow, <country>Poland</country>.</aff>
<aff id="a3"><label>3</label><institution>Department of Plant Cytology and Embryology, Institute of Botany, Jagiellonian University</institution> in Krak&#x00F3;w, Poland, Gronostajowa 9, 30-387 Krakow, <country>Poland</country>.</aff>
<aff id="a4"><label>4</label><institution>nOvum Fertility Clinic</institution>, Bociania 13, 02-807 Warszawa, <country>Poland</country>.</aff>
</contrib-group>
<author-notes>
<fn id="n1" fn-type="equal"><label>&#x00A7;</label><p>equal contribution</p></fn>
<corresp id="cor1"><label>&#x002A;</label>Correspondence to: e-mail: <email>malgorzata.kotula-balak@uj.edu.pl</email></corresp>
</author-notes>
<pub-date pub-type="epub"><year>2018</year></pub-date>
<elocation-id>477901</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>23</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>11</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2018, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="477901.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>Abstract</title>
<p>Leydig cell tumors (LCT) are the most common type of testicular sex cord-stromal tumor. In this report, we implicate the G-coupled estrogen receptor (GPER) and peroxisome proliferator receptor (PPAR) in regulation of lipid homeostasis and the expression of steroidogenesis-controlling molecules in clinical specimens of LCTs and cell line (mouse tumor Leydig cells; MA-10). We also show the general structure and morphology of human LCTs with the use of scanning electron microscopy and light microscopy, respectively. In LCTs, protein immunoblotting and immunohistochemical analysis revealed increased expression of GPER and decreased expression of PPAR&#x03B1;, &#x03B2; and &#x03B3;. Concomitantly, changes in expression pattern of the lutropin receptor (LHR), protein kinase A (PKA), perilipin (PLIN), hormone sensitive lipase (HSL), steroidogenic acute regulatory protein (StAR), translocator protein (TSPO), HMG-CoA synthase (HMGCA), and HMG-CoA reductase (HMGCR) were observed.</p>
<p>Using MA-10 cells treated with GPER and PPAR antagonists (alone and in combination), we demonstrated there is a GPER-PPAR mediated control of cholesterol concentration. In addition, GPER-PPAR&#x03B1; regulated estradiol secretion, while GPER-PPAR&#x03B3; affected cGMP concentration. It is assumed that GPER and PPAR can be altered in LCT, resulting in a perturbed lipid balance and steroidogenesis. In LCTs, the phosphatidylinositol-3-kinase (PI3K)-Akt-mTOR signaling pathway was disturbed. Thus, PI3K-Akt-mTOR, together with cGMP, can play a role in LCT proliferation, growth, and metastasis as well as lipid balance control.</p>
<p>In conclusion, we discuss the implications of GPER-PPAR interaction with lipid metabolism and steroidogenesis controlling-molecules in LCT biology that can be used in future studies as potential targets of diagnostic and therapeutic implementations.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Key words</title>
<kwd>G-coupled estrogen receptor</kwd>
<kwd>peroxisome proliferator-activated receptor</kwd>
<kwd>Leydig cell tumor</kwd>
<kwd>steroidogenesis-controlling molecules</kwd>
<kwd>ultrastructure</kwd>
</kwd-group>
<counts>
<page-count count="51"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Leydig cell tumor (LCT; leydigioma) is the most common non-germ cell gonadal tumor, accounting for 1-3% of all testicular tumors in adults and 4-9% in prepubertal children [<xref ref-type="bibr" rid="c1">1</xref>-<xref ref-type="bibr" rid="c3">3</xref>]. In recent years, a marked increase in the incidence of LCTs has been observed (14.7% of all testicular tumors removed). LCTs are usually benign tumors especially in infancy [<xref ref-type="bibr" rid="c4">4</xref>, <xref ref-type="bibr" rid="c5">5</xref>], although local recurrence or metachronous tumors of the contralateral testis have also been described. Survival after diagnosis of primary LCTs ranged from 2 months to 17 years [<xref ref-type="bibr" rid="c6">6</xref>]. Patients with LCTs usually have symptoms of testicular swelling [<xref ref-type="bibr" rid="c7">7</xref>] or various endocrinological disruptions [<xref ref-type="bibr" rid="c8">8</xref>]. Some patients have associated issues with endocrine symptoms e.g. gynecomastia and decreased libido. Gynecomastia is the main clinical manifestation in adults, but it may also be clinically significant in affected children who undergo precocious puberty [<xref ref-type="bibr" rid="c9">9</xref>]. In the latter, behavioral perturbations were observed [<xref ref-type="bibr" rid="c10">10</xref>]. Some cases of LCTs were linked with increased plasma estradiol concentrations and were merely revealed by gynecomastia [<xref ref-type="bibr" rid="c11">11</xref>,<xref ref-type="bibr" rid="c12">12</xref>]. Moreover, infertility and azoospermia are not an unusual finding in patients with LCTs [<xref ref-type="bibr" rid="c13">13</xref>].</p>
<p>Less than 0.2% of all testicular cancers were evidenced by metastatic spread. Besides retroperitoneal nodes, other metastatic sites are liver, lungs, bone, and mediastinum [<xref ref-type="bibr" rid="c14">14</xref>, <xref ref-type="bibr" rid="c15">15</xref>]. In prepubertal patients, even malignant LCTs are less likely to metastasize. Radical orchiectomy is the current standard of care but testis sparing surgery (TSS) (enucleation), in conjunction with intraoperative frozen section (FSE), has been recently attempted with promising results [<xref ref-type="bibr" rid="c16">16</xref>]. Prepubertal individuals and those with smaller tumors that lack evidence of malignancy are directly recommended for TSS.</p>
<p>The etiology of LCTs is unknown and appears heterogeneous. Furthermore, the molecular basis of LCTs is poorly understood. Some studies showed a possible role of genetic factors in LCT development. Interestingly, genetic mutations identified in children and adults were different and, in some cases, associated with other cancers [<xref ref-type="bibr" rid="c17">17</xref>]. In adults, it was observed that a somatic activating mutation in the guanine nucleotide-binding protein &#x03B1; gene may result in tumor development, leading to overexpression of the inhibin &#x03B1; subunit and hyperactivity of sex steroid biosynthesis [<xref ref-type="bibr" rid="c5">5</xref>]. In addition, Carvajal-Carmona <italic>et al.</italic>, [<xref ref-type="bibr" rid="c18">18</xref>] reported an inherited fumarate hydratase mutation appears to cause tumor growth through activation of the hypoxia pathway. According to study of Lejeune <italic>et al.</italic>, [<xref ref-type="bibr" rid="c11">11</xref>] alterations in local stimuli, including M&#x00FC;llerian-inhibiting hormone, inhibin, growth factors, and temperature, may also create favorable conditions for initiation and development of LCTs.</p>
<p>Decreased Leydig cell function is common in men with reproductive disorders, including testicular dysgenesis syndrome (TDS). This syndrome is comprised of subfertility, cryptorchidism, hypospadias, and testicular cancer that is pathogenetically linked to impaired testis development and function [<xref ref-type="bibr" rid="c19">19</xref>, <xref ref-type="bibr" rid="c20">20</xref>]. Leydig cell impairment manifests as a decreased testosterone/lutropin (LH) ratio and the presence of Leydig cell micronodules in the testis [<xref ref-type="bibr" rid="c21">21</xref>]. Additionally, uncontrolled synthesis and secretion of testosterone may suppress LH secretion and impair spermatogenesis [<xref ref-type="bibr" rid="c22">22</xref>]. The number and size of micronodules (clusters-when Leydig cell number &#x003E;15) increases with the severity of TDS and increasing gonadotrophin levels [<xref ref-type="bibr" rid="c21">21</xref>, <xref ref-type="bibr" rid="c23">23</xref>]. Due to ultrastructural changes demonstrated in Leydig cells within micronodules (decreased smooth endoplasmic reticulum, irregularly indented nuclear membrane, decreased lipofuscin pigment granules, and Reinke crystals) failure of their maturation is suggested [<xref ref-type="bibr" rid="c24">24</xref>, <xref ref-type="bibr" rid="c25">25</xref>]. Also, the proportion of morphologically abnormal Leydig cells was inversely correlated with testosterone levels in patients with primary testicular disorders such as cryptorchidism, Klinefelter syndrome, and Del Castillo's syndrome [<xref ref-type="bibr" rid="c26">26</xref>].</p>
<p>Besides micronodules, other histopathological changes of Leydig cells have been described. In patients with germ cell tumors, Leydig cell hypertrophy and hyperplasia were linked to elevated levels of chorionic gonadotropin [<xref ref-type="bibr" rid="c27">27</xref>]. In addition, various chemicals induce Leydig cell hyperplasia because of disruption of the hypothalamic-pituitary-axis [<xref ref-type="bibr" rid="c28">28</xref>]. Neoplastic proliferation of Leydig cells may result in the synthesis of non-functional steroid hormones. Alternatively, an excess of various hormones (<italic>e.g</italic>. estrogen, prolactin) produce elevated LH levels that excessively stimulate steroidogenic Leydig cell function [<xref ref-type="bibr" rid="c29">29</xref>]. Concomitantly, in experimental studies of animals exposed to hormones, hormonally active chemicals, or other hormonal modulators, Leydig cell hypertrophy was demonstrated [<xref ref-type="bibr" rid="c30">30</xref>-<xref ref-type="bibr" rid="c33">33</xref>]. However, there is no evidence as to whether Leydig cell pathology including micronodules, hyperplasia, and/or hypertrophy may further develop into leydigioma [<xref ref-type="bibr" rid="c34">34</xref>].</p>
<p>Mitogenicity associated with estrogen receptor-mediated cellular events is believed to be the mechanism by which estrogens contribute to tumorigenesis. Currently, implications of estrogen signaling <italic>via</italic> canonical estrogen receptors (ERs), G-protein coupled membrane estrogen receptor (GPER), as well as estrogen-related receptors (ERRs) is recognized in animal and human Leydig cell tumorigenesis [<xref ref-type="bibr" rid="c35">35</xref>-<xref ref-type="bibr" rid="c37">37</xref>]. Until recently, the function of GPER in testicular cells was only partially known. In human testis, Fietz <italic>et al</italic>. [<xref ref-type="bibr" rid="c38">38</xref>, <xref ref-type="bibr" rid="c39">39</xref>] showed high levels of GPER mRNA expression in Leydig cells. In fact, not only is GPER able to bind sex steroids but also binds the peroxisome proliferator-activated receptors (PPARs) [<xref ref-type="bibr" rid="c40">40</xref>]. In amphibians, rodents, and humans, three forms of PPAR have been described to date: PPAR&#x03B1;, PPAR&#x03B2; (also known as PPAR&#x03B4;), and PPAR&#x03B3; [<xref ref-type="bibr" rid="c41">41</xref>]. PPARs target genes that encode enzymes involved in peroxisome and mitochondria function as well as those of fatty acids, apolipoproteins, and lipoprotein lipase. Little is known about PPARs in the male reproductive system. In rat testis, PPARs are mainly expressed in Leydig and Sertoli cells [<xref ref-type="bibr" rid="c42">42</xref>]. It was shown that some PPAR chemicals alter testosterone production [<xref ref-type="bibr" rid="c43">43</xref>], and their long-term administration results in Leydig cell tumor development in rats [<xref ref-type="bibr" rid="c44">44</xref>, <xref ref-type="bibr" rid="c45">45</xref>].</p>
<p>Scarce data are available on the molecular and biochemical characteristics of LCTs. Maintaining an adequate hormonal balance within the testis is the basis for proper gonadal function, thus playing a pivotal role for blocking hormone-secreting Leydig cell tumor development [<xref ref-type="bibr" rid="c46">46</xref>, <xref ref-type="bibr" rid="c47">47</xref>]. Of note, in tumor cells, proliferation, growth, apoptosis, and communication are not only disturbed but other processes as well e.g. lipid metabolism [<xref ref-type="bibr" rid="c48">48</xref>].</p>
<p>It is worth noting that biosynthesis of sex steroids is multi-level, controlled process [<xref ref-type="bibr" rid="c49">49</xref>]. It requires the coordinated expression of number of genes, proteins of various function (receptors e.g. lutropin receptor; LHR, enzymes, transporters e.g. translocator protein; TSPO, steroidogenic acute regulatory protein; StAR, and regulators), signaling molecules (e.g. protein kinase A; PKA), and their regulators in response to LH stimulation. Moreover, for cellular steroidogenic function, global lipid homeostasis is crucial. Perilipin (PLIN), hormone sensitive lipase (HSL), and HMG-CoA synthase (HMGCS) and reductase (HMGCR) are members of a cell structural and enzymatic protein machinery controlling lipid homeostasis [<xref ref-type="bibr" rid="c50">50</xref>]. Activation of lipid metabolism is an early event in tumorigenesis, however, the precise expression pattern of lipid balance-controlling molecules and their molecular mechanism remains poorly characterized.</p>
<p>This study aims to determine the potential link between GPER and PPAR and whether this interaction regulates lipid homeostasis in LCTs. To further investigate the relationship of Leydig cell tumorigenesis to these receptors while elucidating the effects of their interactions mouse tumor Leydig cells (MA-10) were utilized.</p>
</sec>
<sec id="s2">
<title>Materials and Methods</title>
<sec id="s2a">
<label>2.1.</label>
<title>Tissue samples and ethical considerations</title>
<p>Adult samples were residual tissues from testicular biopsy (microdissection TESE, by Schlegel, 1998) specimens collected at the nOvum Fertility Clinic, Warsaw, Poland from patients (31-45 year-old; n&#x003D;24) diagnosed due to azoospermia (micronodules LCTs were recognized during surgery) after written informed consent according to the approval regulations by the National Commission of Bioethics at the Jagiellonian University in Krakow, Poland; permit no. 1072.6120.218.2017 and were carried out in accordance with the Declaration of Helsinki.</p>
<p>After evaluation by pathologists, the remaining tissue fragments were snap-frozen or fixed and paraffin-embedded, and stored at the Department of Endocrinology, Institute of Zoology and Biomedical Research, Jagiellonian University in Krakow, Poland.</p>
</sec>
<sec id="s2b">
<label>2.2.</label>
<title>Cell culture and treatments</title>
<p>The mouse Leydig cell line MA-10 was a generous gift from Dr. Mario Ascoli (University of Iowa, Iowa City, USA), and was maintained under standard technique [51]. Middle passages (p25-p28) of MA-10 cells were used for the study. The cells were grown in Waymouth&#x2019;s media (Gibco, Grand Island, NY) supplemented with 12% horse serum and 50 mg/l of gentamicin at 37 &#x00B0;C in 5% CO<sub>2</sub>. Cells were plated overnight at a density of 1 &#x00D7; 10<sup>5</sup> cells/ml per well. Morphological and biochemical properties of MA-10 cells are regularly checked by microscopic observation, analysis of proliferation (TC20 Bio-Rad automated cell counter), mycoplasma detection (MycoFluor&#x2122; Mycoplasma Detection Kit; ThermoFisher Scientific), qRT-PCR analysis of characteristic genes and ELISA measurements of secretion products according to cell line authentication recommendations of the Global Bioresource Center (ATCC).</p>
<p>Twenty-four hours before the experiments, the medium was removed and replaced with a medium without phenol red supplemented with 5% dextran-coated, charcoal-treated FBS (5% DC-FBS) to exclude estrogenic effects caused by the medium. Next, cells were treated with selective antagonists: GPER [(3a<italic>S</italic>&#x002A;,4<italic>R</italic>&#x002A;,9b<italic>R</italic>&#x002A;)-4-(6-Bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3<italic>H</italic>-cyclopenta[<italic>c</italic>]quinolone; G-15] (Tocris Bioscience, Bristol, UK), PPAR&#x03B1; [<italic>N</italic>-((2<italic>S</italic>)-2-(((1<italic>Z</italic>)-1-Methyl-3-oxo-3-(4-(trifluoromethyl)phenyl)prop-1-enyl)amino)-3-(4-(2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy)phenyl)propyl) propanamide, GW6471] or PPAR&#x03B3; [2-Chloro-5-nitro-<italic>N</italic>-4-pyridinylbenzamide, T0070907] freshly prepared as 100nM stock solutions in dimethyl sulfoxide (DMSO) (Sigma-Aldrich) and stored at &#x2212;20&#x00B0;C. A stock concentrations were subsequently dissolved in Waymouth&#x2019;s media to a final concentrations. Cells were treated with G-15, PPAR&#x03B1; or PPAR&#x03B3; alone or together for 24hours. Doses of G-15 (10nM), PPAR&#x03B1; (10&#x00B5;M) or PPAR&#x03B3; (10&#x00B5;M) [<xref ref-type="bibr" rid="c52">52</xref>]. Control cells were treated with DMSO (final conc. 0.1%). Cell lysates and culture media were frozen in &#x2212;20&#x00B0;C for further analyses.</p>
</sec>
<sec id="s2c">
<label>2.3.</label>
<title>Scanning electron microscopy analysis</title>
<p>LCTs were fixed in a mixture of 2.5% glutaraldehyde with 2.5% formaldehyde in a 0.05 M cacodylate buffer (Sigma; pH 7.2) for seven days, washed three times in a 0.1 M sodium cacodylate buffer and later dehydrated and subjected to critical-point drying. They were then sputter-coated with gold and examined at an accelerating voltage of 20 kV or 10 KV using a Hitachi S-4700 scanning electron microscope (Hitachi, Tokyo, Japan), which is housed in the Institute of Geological Sciences, Jagiellonian University in Krak&#x00F3;w).</p>
</sec>
<sec id="s2d">
<label>2.4.</label>
<title>Histology</title>
<p>For routine histology, hematoxylin-eosin staining was performed on 4% paraformaldehyde LCT sections. As a control paraffin sections of human testis (cat. No. HP-401; Zyagen, San Diego, CA, USA) were used.</p>
</sec>
<sec id="s2e">
<label>2.5.</label>
<title>RNA isolation, reverse transcription and real-time quantitative RT-PCR</title>
<p>Total RNA was extracted from LCTs specimens and human Leydig cells (cat. no 10HU- 103; ixCells Biotechnologies, San Diego CA, USA) using TRIzol<sup>&#x00AE;</sup> reagent (Life Technologies, Gaithersburg, MD, USA) according to the manufacturer&#x2019;s instructions. The yield and quality of the RNA were assessed using a NanoDrop ND2000 Spectrophotometer (Thermo Scientific, Wilmington, DE, USA). Samples with a 260/280 ratio of 1.95 or greater and a 260/230 ratio of 2.0 or greater were used for analysis. Total cDNA was prepared using High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA, USA) according to the manufacturer&#x2019;s instructions.</p>
<p>The purified total RNA was used to generate total cDNA. A volume equivalent to 1 &#x03BC;g of total RNA was reverse transcribed using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA, USA) according to the manufacturer's instructions. Total cDNA was prepared in a 20-&#x03BC;L volume using a random primer, dNTP mix, RNase inhibitor and reverse transcriptase (RT). Parallel reactions for each RNA sample were run in the absence of RT to assess genomic DNA contamination. RNase-free water was added in place of the RT product.</p>
<p>Real-time RT-PCR was performed using the StepOne Real-Time PCR system (Applied Biosystems) and optimized standard conditions as described previously by Kotula-Balak et al. [<xref ref-type="bibr" rid="c53">53</xref>, <xref ref-type="bibr" rid="c54">54</xref>]. Based on the gene sequences in Ensembl database primer sets were designed using Primer3 software (Table, supplementary material). Selected primers were synthesized by Institute of Biochemistry and Biophysics, Polish Academy of Science (Warsaw, Poland). To calculate the amplification efficiency serial cDNA dilution curves were produced for all genes. A graph of threshold cycle (Ct) versus log10 relative copy number of the sample from a dilution series was produced. The slope of the curve was used to determine the amplification efficiency: %E &#x003D; (10&#x2212;<sup>1/slope</sup>-1) &#x00D7; 100. All PCR assays displayed efficiency between 94% and 104%.</p>
<p>Detection of amplification gene products was performed with 10 ng cDNA, 0.5 &#x03BC;M primers, and SYBR Green master mix (Applied Biosystems) in a final volume of 20 &#x03BC;L. Amplifications were performed as follows: 55 &#x00B0;C for 2 min, 94 &#x00B0;C for 10 min, followed by annealing temperature for 30 s (Table 1) and 45 s 72 &#x00B0;C to determine the cycle threshold (Ct) for quantitative measurement. To confirm amplification specificity, the PCR products from each primer pair were subjected to melting curve analysis and subsequent agarose gel electrophoresis (not shown). In all real-time RT-PCR reactions, a negative control corresponding to RT reaction without the reverse transcriptase enzyme and a blank sample were carried out. All PCR products stained with Midori Green Stain (Nippon Genetics Europe GmbH, D&#x00FC;ren, Germany) were run on agarose gels. Images were captured using a Bio&#x2013;Rad Gel Doc XR System (Bio&#x2013;Rad Laboratories, Hercules, CA, USA) (not shown). mRNA expressions were normalized to the <italic>&#x03B2;-actin</italic> mRNA (relative quantification, RQ &#x003D; 1) with the use of the 2<sup>&#x2212;&#x0394;&#x0394;Ct</sup> method.</p>
</sec>
<sec id="s2f">
<label>2.6.</label>
<title>Western blotting</title>
<p>For quantification of protein expression (Table 1) from LCTs proteins (as a control human Leydig cells; cat. No 10HU-103; ixCells Biotechnologies, San Diego CA, USA) were extracted in 50 &#x03BC;l of radioimmunoprecipitation assay buffer (RIPA; Thermo Scientific, Inc. Rockford IL, USA) and protease inhibitor cocktail (Sigma Chemical Co., St. Louis, Missouri, USA). Concentration of proteins was determined with Bradford reagent (Bio-Rad Protein Assay; Bio-Rad Laboratories GmbH, Munchen, Germany), using bovine serum albumin as a standard. Aliquots (50 &#x03BC;g protein) of cell lysates were used for electrophoresis on 12% mini gel by standard SDS-PAGE procedures and electrotransferred to polyvinylidene difluoride (PVDF) membranes (Millipore Corporate, MA, USA) by a semi-dry transfer cell (Bio-Rad). Then, blots were blocked with 5% nonfat dry milk in TBS, 0.1% Tween 20, overnight at 4 &#x00B0;C with shaking, followed by an incubation with respective antibodies (Table 1). The membranes were washed and incubated with a secondary antibody conjugated with the horseradish-peroxidase labeled goat anti-mouse or goat anti-rabbit IgGs (Vector Labs., Burlingame, CA, USA) at a dilution 1:1000, for 1 h at RT. Immunoreactive proteins were detected by chemiluminescence with Western Blotting Luminol Reagent (Santa Cruz Biotechnology), and images were captured with a ChemiDoc XRS &#x002B; System (Bio-Rad Laboratories). All immunoblots were stripped with stripping buffer containing 62.5 mM Tris&#x2013;HCl, 100 mM 2-mercaptoethanol, and 2% SDS (pH 6.7) at 50 &#x00B0;C for 30 min and incubated in a rabbit polyclonal antibody against &#x03B2;-actin. Each data point was normalized against its corresponding &#x03B2;-actin data point.</p>
<p>To obtain quantitative results, immunoblots were scanned with Image Lab 2.0 (Bio-Rad Laboratories). Then, a bound antibody was revealed using DAB as the substrate. Finally, the membranes were dried and then scanned using Epson Perfection Photo Scanner (Epson Corporation, CA, USA). Molecular masses were estimated by reference to standard proteins (Prestained SDS-PAGE Standards, Bio-Rad Labs, GmbH, Munchen, Germany). Quantitative analysis was performed for three separately repeated experiments using a public domain ImageJ software (National Institutes of Health, Bethesda, MD) as described elsewhere [<xref ref-type="bibr" rid="c55">55</xref>]. The relative protein levels were expressed as arbitrary units.</p>
<p>2.7 Immunohistochemistry</p>
<p>To optimize immunohistochemical staining testis sections both control (Zyagen, San Diego, CA, USA) and LCTs sections were immersed in 10 mM citrate buffer (pH 6.0) and heated in a microwave oven (2 &#x00D7; 5 min, 700 W). Thereafter, sections were immersed sequentially in H<sub>2</sub>O<sub>2</sub> (3 %; v/v) for 10 min and normal goat serum (5 %; v/v) for 30 min which were used as blocking solutions. After overnight incubation at 4 &#x00B0;C with primary antibodies listed in Table 1. Next respective biotinylated antibodies (anti-rabbit and anti-mouse IgGs; 1: 400; Vector, Burlingame CA, USA) and avidin-biotinylated horseradish peroxidase complex (ABC/HRP; 1:100; Dako, Glostrup, Denmark) were applied in succession. Bound antibody was visualized with 3,3&#x2019;-diaminobenzidine (DAB) (0.05 %; v/v; Sigma-Aldrich) as a chromogenic substrate. Control sections included omission of primary antibody and substitution by irrelevant IgG.</p>
</sec>
<sec id="s2g">
<label>2.8.</label>
<title>Cholesterol assay</title>
<p>The Amplex<sup>&#x00AE;</sup> Red Cholesterol Assay Kit (Molecular Probes Inc., Eugene, OR, USA) was used for cholesterol content (&#x00B5;M) analysis in control and treated with GPER and PPAR (alone or in combinations) MA-10 cells. For measurement 100 &#x00B5;l cell lysates was used according to manufacturer&#x2019; s protocol. Data were expressed as mean &#x00B1; SD. The fluorescence (&#x03BB; &#x003D; 580 nm) was measured with the use of a fluorescence multiwell plate reader SPARK Tecan, Switzerland.</p>
</sec>
<sec id="s2h">
<label>2.9.</label>
<title>cGMP concentration and estradiol secretion</title>
<p>The production of cGMP in control and treated with GPER and PPAR (alone or in combinations) MA-10 cells was measured by General Cyclic guanosine monophosphate Elisa kit assay (EIAab Wuhan Eiaab Science Co., LTD, Wuhan, China) according to the manufacturer&#x2019;s instructions with detection level 0.31 to 20.0 ng/mL. The cGMP levels were calculated as ng/mL.</p>
<p>Estradiol Enzyme Immunoassay Kit (DRG, Inc. Int. Springfield, USA) was used for measurement of estradiol content in culture medium from control and treated with GPER and PPAR (alone or in combinations) MA-10 cells according to the manufacturer's instructions. The sensitivity of the assay was 10.6 pg/mL. The absorbance (&#x03BB; &#x003D; 450 nm) was measured. Data were expressed as mean &#x00B1; SD.</p>
<p>The measurements were performed with the use ELISA apparatus (Labtech LT-4500).</p>
</sec>
<sec id="s2i">
<label>2.10.</label>
<title>Statistics</title>
<p>Three biological repeats of each sample (n &#x003D; 7) and three independent experiments were performed. Each variable was tested using the Shapiro-Wilk W-test for normality. The homogeneity of variance was assessed with Levene&#x2019;s test. Comparisons were performed by one-way ANOVA, followed by Dunnett&#x2019;s post hoc test (GB-STAT software, v. 7.0; Dynamic Microsystems) to determine the significant differences between proteins expression levels, and cholesterol content, cGMP content and estradiol secretion. Statistical analyses were performed on raw data using Statistica 10 software (StatSoft Inc., Tulsa, OK, USA). Data were presented as means <italic>&#x00B1;</italic> S.D. Data were considered statistically significant at &#x2217; <italic>p</italic> &#x003C; 0.05, &#x2217;&#x2217; <italic>p</italic> &#x003C; 0.01 and &#x2217;&#x2217;&#x2217;<italic>p</italic> &#x003C; 0.001.</p>
</sec>
</sec>
<sec id="s3">
<title>Results</title>
<sec id="s3a">
<label>3.1.</label>
<title>Scanning electron microscopic and morphological observations of LCTs</title>
<p>Scanning electron microscopy analyses of LCT biopsy fragments revealed the tumors are relatively compact structures of oval or slightly elongated shape (<xref rid="fig1" ref-type="fig">Fig.1a A-C</xref>) with tumor cells apposed and adhering to one another (<xref rid="fig1" ref-type="fig">Fig.1a D, E</xref>). It is important to note that some tumor cells were fused. Our observations also revealed that compact areas of tumor cells are separated by deep grooves. Between those grooves, compact tumor sheets are formed (<xref rid="fig1" ref-type="fig">Fig.1b E-G</xref>). Cells within sheets are tightly linked by thick projections and masses of such connections were observed between cells from neighboring tumor sheets (<xref rid="fig1" ref-type="fig">Fig.1b E &#x2013;F</xref>). Higher magnification revealed the presence of elongated, delicate filiform fibrillar projections that form a cage-like structure covering individual tumor sheets (<xref rid="fig1" ref-type="fig">Fig.1b I &#x2013; L</xref>).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Morphology of human Leydig cell tumors &#x2013; scanning electron microscopic analysis</title>
<p>(1a A-F and 1b G-L) Representative microphotographs of scanning electron microscopic analysis of human Leydig cell tumors (LCTs). Bars represent 1&#x00B5;m. For analysis n &#x003D; 12 specimens were used.</p></caption>
<graphic xlink:href="477901v1_fig1a.tif"/>
<graphic xlink:href="477901v1_fig1b.tif"/>
</fig>
<p>Hematoxylin-eosin staining demonstrated a mixture of four types of cells in the tumor mass when compared to controls, where single or small groups of Leydig cells were seen in the interstitial space (<xref rid="fig2" ref-type="fig">Fig.2 A, B</xref>). In LCTs, most cells possessed a large polygonal shape with abundant cytoplasm, indistinct cell borders, and regular round to oval nuclei. The nucleus was found to be frequently prominent (<xref rid="fig2" ref-type="fig">Fig. 2b</xref>). Occasionally, cells as those noted above were found to possess distinct cell borders and smaller nuclei (<xref rid="fig2" ref-type="fig">Fig. 2b</xref>&#x2019;). Small cells with scant, densely eosinophilic cytoplasm and a grooved nuclei (<xref rid="fig2" ref-type="fig">Fig. 2b</xref>&#x201D;) and spindle-shaped (sarcomatoid) cells (<xref rid="fig2" ref-type="fig">Fig. 2b</xref>&#x201D;&#x2019;) were observed as well.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Morphology of human Leydig cell tumors &#x2013; hematoxylin-eosin staining</title>
<p>Representative microphotographs of (A) control human testis and (B, b-b&#x2019;&#x2019;&#x2019;) Leydig cell tumors (LCTs). Scale bars represent 15 &#x03BC;m. Staining was performed on serial testicular sections from n &#x003D; 12 specimens.</p>
<p>LC-Leydig cells, EC - epithelial cells of blood vessels</p>
<p>(b) - arrows depict cells of large polygonal shape with abundant, cytoplasm, indistinct cell borders, and regular, round to oval nuclei. Prominent nucleus visible at (b) higher magnification (arrowheads), (b&#x2019;) - arrows depict cells with above features but possessing distinct cell borders and smaller nuclei, (b&#x2019;&#x2019;) - arrows depict small cells with scant, densely eosinophilic cytoplasm and grooved nuclei, (b&#x2019;&#x2019;&#x2019;) &#x2013; arrows depict spindle-shaped (sarcomatoid) cells.</p></caption>
<graphic xlink:href="477901v1_fig2.tif"/>
</fig>
</sec>
<sec id="s3b">
<label>3.2.</label>
<title>Expression and localization of GPER and PPARs in LCTs</title>
<p>In LCTs, increased expression of GPER (<italic>p</italic> &#x003C; 0.05) and decreased expression of PPAR&#x03B1; (<italic>p</italic> &#x003C; 0.001), PPAR&#x03B2; (<italic>p</italic> &#x003C; 0.01), and PPAR&#x03B3; (<italic>p</italic> &#x003C; 0.001) was seen when compared to controls (<xref rid="fig3" ref-type="fig">Fig.3A, B</xref>). Corresponding to GPER and PPARs protein expression changes their mRNA expressions in LCTs are presented as supplementary material (<xref rid="fig3a" ref-type="fig">Fig.3&#x2019;</xref>).</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>Expression of GPER, PPAR&#x03B1;, PPAR&#x03B2; and PPAR&#x03B3; in human Leydig cell tumor.</title>
<p>(A) Representative blots of qualitative expression of GPER, PPAR&#x03B1;, and PPAR&#x03B3; and (B) relative expression (relative quantification of protein density (ROD); arbitrary units). The relative amount of respective proteins normalized to &#x03B2;-actin. ROD from three separate analyses is expressed as means &#x00B1; SD. Asterisks show significant differences between respective control and Leydig cell tumor (LCTs). Values are denoted as &#x2217; <italic>p</italic> &#x003C; 0.05, &#x2217;&#x2217; <italic>p</italic> &#x003C; 0.01 and &#x2217;&#x2217;&#x2217;<italic>p</italic> &#x003C; 0.001. Analysis was performed in triplicate (n &#x003D; 7).</p></caption>
<graphic xlink:href="477901v1_fig3.tif"/>
</fig>
<fig id="fig3a" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>Expression of GPER, PPAR&#x03B1;, PPAR&#x03B2; and PPAR&#x03B3; mRNA in human Leydig cell tumor.</title>
<p>Relative level (relative quantification; RQ) of mRNA for <bold>GPER, PPAR&#x03B1;, PPAR&#x03B2; and PPAR&#x03B3;</bold> determined using real-time RT-PCR analysis 2&#x2212;&#x0394;Ct method. As an intrinsic control, &#x03B2;-actin mRNA level was measured in the samples. RQ from three separate analyses is expressed as means &#x00B1; SD. Asterisks show significant differences between respective control and Leydig cell tumor (LCTs). Values are denoted as &#x2217; <italic>p</italic> &#x003C; 0.05, and &#x2217;&#x2217;&#x2217;<italic>p</italic> &#x003C; 0.001. Analysis was performed in triplicate (n &#x003D; 7).</p></caption>
<graphic xlink:href="477901v1_fig3a.tif"/>
</fig>
<p>No changes in GPER localization and staining intensity was found in control Leydig cells and LCTs (<xref rid="fig4" ref-type="fig">Fig.4 A, A&#x2019;</xref>). Specifically, the staining was exclusively cytoplasmic and of moderate intensity. Localization and immunostaining intensity of PPAR varied between Leydig cells of control testis and LCTs (Fig.4B, B&#x2019;, C, C&#x2019;, D, D&#x2019;). While strong cytoplasmic-nuclear expression of PPAR&#x03B1;, &#x03B2;, and &#x03B3; was found in control samples, an absence of PPAR&#x03B1; expression and moderate to weak immunostaining expression of PPAR&#x03B2; and PPAR&#x03B3;, respectively, were detected. In LCTs, PPARs were located primarily in the cytoplasm of Leydig cells. No positive staining was found when primary antibodies were omitted (<xref rid="fig4" ref-type="fig">Fig. 4</xref>, inserts at A, D&#x2019;).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Localization of GPER, PPAR&#x03B1;, PPAR&#x03B2; and PPAR&#x03B3; in human Leydig cell tumor.</title>
<p>Representative microphotographs of cellular localization of GPER (A, A&#x2019;), PPAR&#x03B1; (B, B&#x2019;), PPAR&#x03B2; (C, C&#x2019;) and PPAR&#x03B3; (D, D&#x2019; and higher magnification at D) in control human testes (A-D and higher magnification at D) and Leydig cell tumor (LCTs). DAB immunostaining with hematoxylin counterstaining. Scale bars represent 15 &#x03BC;m. Staining was performed on serial testicular sections from n &#x003D; 12 specimens.</p>
<p>Arrows depict cytoplasmic staining, arrowheads depict nuclear staining. No positive staining is seen when the primary antibodies were omitted &#x2013; insert at A and D&#x2019;-(negative controls).</p></caption>
<graphic xlink:href="477901v1_fig4.tif"/>
</fig>
</sec>
<sec id="s3c">
<label>3.3.</label>
<title>Expression and localization of LHR, PKA, PLIN, HSL, StAR, TSPO, HMGCS and HMGCR in LCTs</title>
<p>In LCTs, varying expression of LHR, PKA, PLIN, HSL, StAR, TSPO, HMGCS, and HMGCR was observed when compared to normal Leydig cells (<xref rid="fig5" ref-type="fig">Fig. 5A</xref>, B). The expression of LHR and PKA was increased (<italic>p</italic> &#x003C; 0.05 and <italic>p</italic> &#x003C; 0.01, respectively) as well as that of HMGCS and HMGCR (<italic>p</italic> &#x003C; 0.001 and <italic>p</italic> &#x003C; 0.05, respectively). In contrast, PLIN and StAR expression was decreased (<italic>p</italic> &#x003C; 0.001 and <italic>p</italic> &#x003C; 0.05, respectively), while a non-significant increase was observed for HSL and TSPO. Corresponding to LHR, PKA, PLIN, HSL, StAR, TSPO, HMGCS, and HMGCR protein expression changes their mRNA expressions in LCTs are presented as supplementary material (<xref rid="fig5a" ref-type="fig">Fig.5&#x2019;</xref>).</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>Expression of LHR, PKA, PLIN, HSL, StAR, TSPO, HMGCS and HMGCR in human Leydig cell tumor.</title>
<p>(A) Representative blots of qualitative expression of LHR, PKA, PLIN, HSL, PLIN, StAR, TSPO, HMGCS and HMGCR and (B) relative expression (relative quantification of protein density (ROD); arbitrary units). The relative amount of respective proteins normalized to &#x03B2;-actin. ROD from three separate analyses is expressed as means &#x00B1; SD. Asterisks show significant differences between respective control and Leydig cell tumor (LCTs). Values are denoted as &#x2217; <italic>p</italic> &#x003C; 0.05, &#x2217;&#x2217; <italic>p</italic> &#x003C; 0.01 and &#x2217;&#x2217;&#x2217;<italic>p</italic> &#x003C; 0.001. Analysis was performed in triplicate (n &#x003D; 7).</p></caption>
<graphic xlink:href="477901v1_fig5.tif"/>
</fig>
<fig id="fig5a" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>Expression of LHR, PKA, PLIN, HSL, PLIN, StAR, TSPO, HMGCS and HMGCR mRNA in human Leydig cell tumor.</title>
<p>Relative level (relative quantification; RQ) of mRNA for LHR, PKA, PLIN, HSL, PLIN, StAR, TSPO, HMGCS and HMGCR determined using real-time RT-PCR analysis 2&#x2212;&#x0394;Ct method. As an intrinsic control, &#x03B2;-actin mRNA level was measured in the samples. RQ from three separate analyses is expressed as means &#x00B1; SD. Asterisks show significant differences between respective control and Leydig cell tumor (LCTs). Values are denoted as &#x2217; <italic>p</italic> &#x003C; 0.05, &#x2217;&#x2217; <italic>p</italic> &#x003C; 0.01 and &#x2217;&#x2217;&#x2217;<italic>p</italic> &#x003C; 0.001. Analysis was performed in triplicate (n &#x003D; 7).</p></caption>
<graphic xlink:href="477901v1_fig5a.tif"/>
</fig>
<p>In control Leydig cells and LCTs, cytoplasmic expression of LHR was found (Fig.6 A, A&#x2019;). The immunostaining was of moderate intensity in control Leydig cells but was weak and present in minority of cells of LCTs. No differences were found in PKA distribution and immunostaining (<xref rid="fig6" ref-type="fig">Fig. 6</xref> B, B&#x2019;), with strong staining present in control and tumor Leydig cell cytoplasm. PLIN distribution was cytoplasmic in control Leydig cells and LCTs (<xref rid="fig6" ref-type="fig">Fig. 6</xref> C, C&#x2019;). In control Leydig cells, staining intensity was strong while found to be weak in LCTs. Increased HSL staining intensity was found in LCTs when compared to control cells (<xref rid="fig6" ref-type="fig">Fig. 6D</xref>, D&#x2019;) and was exclusively cytoplasmic. Strong immunoreaction was found in the blood vessel epithelium. In contrast, decreased staining intensity of StAR, exclusively present in the cytoplasm, was observed in LCTs (<xref rid="fig6" ref-type="fig">Fig. 6E</xref>, E&#x2019;) while control Leydig cells exhibited moderate cytoplasmic staining. A similar pattern was found for TSPO (<xref rid="fig6" ref-type="fig">Fig. 6</xref> F, F&#x2019;). Moderate cytoplasmic expression was revealed in control Leydig cell cytoplasm, while the TSPO staining intensity was very weak in LCTs. However, in a few cells immunoreaction was very strong. No differences were found in the distribution of HMGCS and HMGCR between control cells and LCTs (<xref rid="fig6" ref-type="fig">Fig. 6</xref> G, G&#x2019; and H, H&#x2019;). Strong cytoplasmic expression of HMGCS and moderate cytoplasmic expression of HMGCR were revealed in control Leydig cells and LCTs, respectively. No positive staining was found when primary antibodies were omitted (<xref rid="fig4" ref-type="fig">Fig. 4</xref>, inserts at A, F&#x2019;).</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>Localization of LHR, PKA, PLIN, HSL, StAR, TSPO, HMGCS and HMGCR in human Leydig cell tumor.</title>
<p>Representative microphotographs of cellular localization of LHR (A-A&#x2019;), PKA (B-B&#x2019;), PLIN(C-C&#x2019; and higher magnifications at C and C&#x2019;), HSL (D-D&#x2019;), StAR (E-E&#x2019;), TSPO (F-F&#x2019;), HMGCS (G-G&#x2019;) and HMGCR (H-H&#x2019;) in control human testes (A-H and higher magnification at C) and Leydig cell tumor (A&#x2019;-H&#x2019; and higher magnification at C&#x2019;). DAB immunostaining with hematoxylin counterstaining. Scale bars represent 15 &#x03BC;m. Staining was performed on serial testicular sections from n &#x003D; 12 specimens. Arrows depict cytoplasmic staining. Arrowheads depict strong stained cells for TSPO and positively stained epithelial cells of blood vessels for HSL. No positive staining is seen when the primary antibodies were omitted &#x2013; insert at A and F&#x2019;-(negative controls).</p></caption>
<graphic xlink:href="477901v1_fig6.tif"/>
</fig>
</sec>
<sec id="s3d">
<label>3.4.</label>
<title>Effect of GPER and PPAR blockage on expression of PI3K, Akt and mTOR in LCTs</title>
<p>In LCTs, PI3K and Akt expression was increased (<italic>p</italic> &#x003C; 0.05,) while no observable changes in mTOR expression was found when compared to controls (<xref rid="fig5" ref-type="fig">Fig. 5A</xref>, B).</p>
</sec>
<sec id="s3e">
<label>3.5.</label>
<title>Effect of GPER and PPAR blockage on cholesterol concentration, estradiol secretion and cGMP concentration in MA-10 cells</title>
<p>Regardless of used antagonists (alone or in combination), an increased (<italic>p</italic> &#x003C; 0.05, <italic>p</italic> &#x003C; 0.01) cholesterol concentration in tumor Leydig cells was seen (<xref rid="fig8" ref-type="fig">Fig. 8A</xref>). Secretion of estradiol markedly increased (<italic>p</italic> &#x003C; 0.001) after GPER blockage (Fig.8B). A similar increase (<italic>p</italic> &#x003C; 0.01) was observed after GPER and PPAR&#x03B1; blockage. Conversely, blockage of GPER and PPAR&#x03B3; decreased (<italic>p</italic> &#x003C; 0.05) estradiol secretion. When either PPAR&#x03B1; or PPAR&#x03B3; was blocked, no to little alterations (<italic>p</italic> &#x003C; 0.05) in hormone secretion were revealed.</p>
<p>Changes in cGMP concentration after antagonist-treatment were similar to those of estradiol secretion (Fig.8C). Treatment with a GPER antagonist, alone or in combination with a PPAR&#x03B1; antagonist, increased (<italic>p</italic> &#x003C; 0.05, <italic>p</italic> &#x003C; 0.01) cGMP concentration while treatment with PPAR&#x03B1; or &#x03B3; antagonists consistently decreased (<italic>p</italic> &#x003C; 0.05) the concentration. Only treatment with GPER and PPAR&#x03B3; antagonists in combination increased (<italic>p</italic> &#x003C; 0.01) cGMP concentration.</p>
</sec>
</sec>
<sec id="s4">
<title>Discussion</title>
<p>In the present study, we examined the cellular organization and molecular mechanisms, including GPER and PPAR signaling, lipid balance, and steroidogenesis-regulating molecular interactions that regulate LCT biology.</p>
<p>For the first time, scanning electron microscopic analysis was used to visualize the general organization of LCTs. We showed a complicated LCT structure where individual cells were not recognized in the solid mass, but a number of prolongations of various size were formed, keeping cells tightly linked to each other. Of note, according to Kim <italic>et al.,</italic> [<xref ref-type="bibr" rid="c14">14</xref>] and Al-Agha and Axiotis [<xref ref-type="bibr" rid="c56">56</xref>], benign LCTs classically present as a small (3&#x2013;5 cm in diameter), sharply delineated and solid mass embedded within the testis. Alternatively, malignant LCTs are typically larger (greater than 5 cm in diameter), have infiltrative margins, and show areas of hemorrhage and necrosis. They replace the testis and/or extend beyond testicular parenchyma. Morphologically, LCTs can consist predominantly of one type or as a mixture of the four types of cells [<xref ref-type="bibr" rid="c57">57</xref>] observed in specimens examined herein. Pale to clear cytoplasm of LCTs, related to abundant lipid accumulation, was reported by Al-Agha and Axiotis [<xref ref-type="bibr" rid="c56">56</xref>]. Other characteristic frequently observed is a rich cytoplasmic lipofuscin pigment that is distinctive for LCT, although it is present in other steroid hormones-secreting tumors as well as in aging cells [<xref ref-type="bibr" rid="c3">3</xref>]. Additionally, Reinke crystals, both intracytoplasmic and intranuclear, are often described in LCTs. Ultrastructural studies of LCTs revealed organelle content typical for steroid-secreting cells e.g. abundant smooth endoplasmic reticulum, mitochondria with tubulovesicular cristae, and numerous lipid droplets or irregularly shaped electron-dense bodies consisting of lipid droplets and accumulated in lysosomes [<xref ref-type="bibr" rid="c58">58</xref>].</p>
<p>Leydig cell tumors are sex steroid hormone-secreting tumors with androgens produced in prepubertal children and estrogens in adults [<xref ref-type="bibr" rid="c10">10</xref>]. A central factor in LCT growth and progression is represented by an inadequate intratesticular balance in the androgen/estrogen ratio [<xref ref-type="bibr" rid="c59">59</xref>]. Sirianni <italic>et al.,</italic> [<xref ref-type="bibr" rid="c60">60</xref>] demonstrated that estrogens elicit proliferative effects in human and rodent tumor Leydig cells through an autocrine mechanism. Findings from transgenic mice revealed an increased estrogen/androgen ratio, and estrogen excess resulted in Leydig cell hyperplasia, hypertrophy, and adenomas [<xref ref-type="bibr" rid="c61">61</xref>]. Of note, these effects can be induced by the action of estrogen <italic>via</italic> canonical estrogen receptors. Varying expression patterns of ER&#x03B1; and ER&#x03B2; were observed in human LCTs compared to healthy testis [<xref ref-type="bibr" rid="c36">36</xref>]. Also, in human and rat LCTs, involvement of GPER in cell proliferation, growth, and apoptosis was shown [<xref ref-type="bibr" rid="c62">62</xref>]. Rago <italic>et al.,</italic> [<xref ref-type="bibr" rid="c63">63</xref>, <xref ref-type="bibr" rid="c64">64</xref>] confirmed the presence of GPER in germ cell tumors and sex-cord stromal tumors. From the latter group, in LCTs, the authors found no differences in GPER expression in relation to normal testis. In contrast, we revealed an increase in GPER expression in LCTs when compared to normal Leydig cells. Moreover, in preliminary <italic>in vitro</italic> experiments in mouse tumor Leydig cells, GPER expression was increased [<xref ref-type="bibr" rid="c54">54</xref>].</p>
<p>Herein, we showed GPER, alone and together with PPAR&#x03B1;, effected estradiol secretion by tumor Leydig cells, although GPER and PPAR increased cholesterol levels in these cells. Such results indicate a leading role of GPER over PPAR in regulation of sex hormone production and secretion, and it suggests possible GPER and PPAR&#x03B1; alterations in LCTs. Similarly, our prior study also showed progesterone secretion modulation in GPER and PPAR antagonists-treated tumor mouse Leydig cells [<xref ref-type="bibr" rid="c52">52</xref>]. According to findings by Chimento <italic>et al.,</italic> [<xref ref-type="bibr" rid="c62">62</xref>], GPER is a good target for reduction of tumor Leydig cell proliferation. In tumor rat Leydig cells (R2C), GPER activation by its agonist (G-1) was associated with the initiation of the intrinsic apoptotic mechanism. Other experimental studies showed that endocrine disrupting chemicals, acting through GPER signaling, are involved in testicular germ cell carcinogenesis [<xref ref-type="bibr" rid="c37">37</xref>].</p>
<p>Interestingly, androgens have been shown to inhibit tumor Leydig cell proliferation by opposition to self-sufficient <italic>in situ</italic> estrogen production in R2C cells [<xref ref-type="bibr" rid="c46">46</xref>]. Androgen treatment significantly decreased the expression and activity of estrogen synthase (aromatase). This inhibitory effect relied on androgen receptor (AR) activation and involved negative regulation of the aromatase gene (<italic>CYP19</italic>) transcriptional activity through the nuclear orphan receptor DAX-1 (dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1). Alternatively, the negative role of anabolic androgenic steroids in supraphysiologic dosage was recently implicated in mechanisms of tumorigenesis <italic>via</italic> impairment of the expression of steroidogenic enzymes and effects on intratesticular hormonal balance [<xref ref-type="bibr" rid="c65">65</xref>]. Of note, male patients with congenital adrenal hyperplasia (CAH) can develop bilateral testicular adrenal rest tumors (TARTs). These tumors, in most cases, regress with glucocorticoid therapy but histological differentiation from Leydig-cell tumors is quite difficult [<xref ref-type="bibr" rid="c66">66</xref>]. Ulbright <italic>et al.,</italic> [<xref ref-type="bibr" rid="c3">3</xref>] reported unusual features of LCTs e.g. adipose differentiation, calcification with ossification, and spindle-shaped tumor cells in both young and ageing patients. Awareness of these features may prevent misinterpretation.</p>
<p>Two standards are currently used to distinguish between hyperplastic nodules from adenomas. An adenoma classification is warranted if its diameter exceeds either one seminiferous tubule cross-section [<xref ref-type="bibr" rid="c67">67</xref>] or three seminiferous tubule cross-sections [<xref ref-type="bibr" rid="c69">69</xref>]. Leydig cell hyperplasia (focal or diffuse) and adenomas are commonly observed in laboratory rodents. The spontaneous incidence of adenomas in ageing Sprague-Dawley and inbred Fischer 344 rats, as well as mature CD-l and B6C3Fl mice, have been documented [<xref ref-type="bibr" rid="c68">68</xref>]. Morphologically, no differences appear between spontaneous or chemically induced Leydig cell adenomas [<xref ref-type="bibr" rid="c69">69</xref>].</p>
<p>Increased PPAR expression in organ pathophysiology e.g. liver, heart, intestine, and renal proximal tubules, is currently only partially elucidated [<xref ref-type="bibr" rid="c70">70</xref>-<xref ref-type="bibr" rid="c73">73</xref>]. We showed, for the first time, a PPAR expression pattern in normal human Leydig cells and its prominent down regulation in LCT. Immunoreactive PPAR&#x03B1; and &#x03B2; were clearly apparent in testicular germ cell tumors [<xref ref-type="bibr" rid="c74">74</xref>]. A similar correlation was found in dog testis, and PPAR expression was always markedly higher in tumor tissue [<xref ref-type="bibr" rid="c75">75</xref>]. Recently, Kadivr <italic>et al.,</italic> [<xref ref-type="bibr" rid="c76">76</xref>] reported a relationship between PPAR mRNA expression and spermatozoa motility in rams. Notably, confusing results were seen concerning the involvement of PPAR in tumor biology. PPAR was revealed to both promote and inhibit cancer <italic>via</italic> effects on cell differentiation, growth, metastasis, and lipid metabolism [<xref ref-type="bibr" rid="c77">77</xref>].</p>
<p>In our findings, both <italic>in vivo</italic> and <italic>in vitro</italic> studies revealed a partnership between GPER, PPAR, and lipid homeostasis-controlling molecules in LCT. These molecules showed altered expression patterns in relation to GPER and PPAR expression in LCT.</p>
<p>The effect of either GPER or PPAR on cholesterol content suggests alterations in cholesterol synthesis and/or storage that may be based on GPER and/or PPAR disturbances. Recent studies have also linked lipids abundance with increased tumor aggressiveness and its resistance to chemotherapy [<xref ref-type="bibr" rid="c78">78</xref>]. Wang <italic>et al.,</italic> [<xref ref-type="bibr" rid="c79">79</xref>] reported high cholesterol content and infertility in HSL knockout mice; however, no information on Leydig cell function was provided. Our studies revealed HSL expression was not disturbed in LCTs. Findings by Christian <italic>et al.,</italic> [<xref ref-type="bibr" rid="c80">80</xref>] showed that autophagy influences lipid metabolism <italic>via</italic> both lipogenesis (supporting cell growth within nutrient-limited areas, thereby contributing to tumor symbiotic relationships) and lipolysis. Lipid droplets may induce autophagy and undergo lipophagy to avoid lipotoxicity, a phenomenon caused by excessive lipid accumulation with involvement of the mTOR signaling pathway [<xref ref-type="bibr" rid="c81">81</xref>]. Thus, we show increased cholesterol content without activated mTOR can indirectly result in lipophagy induction in LCTs. It seems this particular tumor can have a distinct biology, but it is possible that some mechanisms can be induced later when its development is more advanced.</p>
<p>Lastly, findings by Ma <italic>et al</italic>., [<xref ref-type="bibr" rid="c82">82</xref>] demonstrated that culture of rat Leydig cells in hypoxic conditions decreased cholesterol content. These findings indicate that, besides well-known lipid homeostasis controlling molecules, a number of factors of various origin/nature are implicated in its regulation. In steroidogenic cells, the mechanism underlying lipid turnover and receptor involvement remained unanswered [<xref ref-type="bibr" rid="c77">77</xref>] however, based on these results, GPER-PPAR cross-talk should be taken into consideration. The question also arises whether some of these factors and/or molecules, when disturbed, lead to Leydig cell tumorigenesis with additional perturbations in lipid homeostasis/steroidogenesis, or whether perturbations in lipid homeostasis-controlling factors/molecules occur as a result of tumor initiation and development. Based on all of the aforementioned results, both mechanisms are equally possible.</p>
<p>The color of LCTs usually ranges from brown to yellow to gray-white depending on the lipid content of the tumor [<xref ref-type="bibr" rid="c83">83</xref>]. The golden-brown appearance (usually imparted by the abundant lipofuscin pigment of tumor cells) is very characteristic. According to our results, in LCTs, lipid homeostasis is disturbed as seen for other endocrine and non-endocrine tumors [<xref ref-type="bibr" rid="c84">84</xref>]. Various changes were revealed in expression and localization of lipid balance-controlling molecules, including those controlling steroidogenesis as well as phosphatidylinositol-3-kinase (PI3K)-Akt-mTOR signaling pathway. Scarce data concerning lipid homeostasis and/or its controlling molecules in rodent tumor Leydig cells are available.</p>
<p>The steroidogenic function of Leydig cells can be modulated in various physiological conditions. <italic>In vivo</italic> studies in young and ageing rats revealed increased sex steroid synthesis in animals administered with a TSPO ligand (FGIN-1-27) [<xref ref-type="bibr" rid="c85">85</xref>]. In both age groups, serum testosterone levels increased significantly. Herein, HSL and TSPO expression did not vary in LCTs, suggesting a subordinate role of these molecules in LCTs. In the Leydig cell line (M5480), an acute effect of hCG was observed as increased metabolism of cholesteryl esters was reported [<xref ref-type="bibr" rid="c87">87</xref>]. Moreover, in patients with testicular cancer, hCG treatment caused excess of estradiol secretion by the tumor [<xref ref-type="bibr" rid="c88">88</xref>]. In a mouse tumor Leydig cell line (mLTC-1), epidermal growth factor increased StAR activity and steroid production efficiency in a time- and dose-dependent manner with involvement of ERK, while LHR expression was significantly reduced [<xref ref-type="bibr" rid="c88">88</xref>]. In mice (C57BL/6J) with LCTs, cessation of steroidogenesis was present when LH and cAMP were removed [<xref ref-type="bibr" rid="c89">89</xref>]. We found prominent changes in LHR and PKA expression, reflecting disturbances in lipid controlling mechanisms directly associated with central endocrine regulation and the local microenvironment. For example, due to implications of HMGCR in cancer cell proliferation and cooperation with Ras signaling, HMGCR is used as a molecular target of statins, cholesterol-lowering drugs [<xref ref-type="bibr" rid="c90">90</xref>].</p>
<p>Metabolic flux and availability of lipids is controlled directly by lipid droplets and peroxisomes. These lipids serve as membrane stabilizers and structural elements, protein modifiers and signaling molecules, as well as energy sources for cell growth, migration, and invasion [<xref ref-type="bibr" rid="c91">91</xref>,<xref ref-type="bibr" rid="c92">92</xref>]. Therefore, failure of one of the lipid machinery components results in a negative effect on global cell physiology and lipid homeostasis. In pancreatic cancer, the content of lipid droplets is mobilized under a restricted cholesterol-rich, low-density lipoprotein (LDL) supply. Limiting LDL uptake reduces the oncogenic properties of this cancer and renders it more sensitive to cytotoxic drugs [<xref ref-type="bibr" rid="c93">93</xref>].</p>
<p>It is worth noting that lipid droplet associated proteins are actively involved in modulating lipid homeostasis by generating sites for steroidogenic enzyme activity [<xref ref-type="bibr" rid="c94">94</xref>, <xref ref-type="bibr" rid="c95">95</xref>]. Marked expression changes in PLIN reflect that it can affect steroidogenic enzymes, thereby aiding in the development of LCTs. Upon stimulation of mLTC-1 cells with LH or 8-bromo-cAMP, large lipid droplets become much smaller and are dispersed throughout the cytosol. Lukyaenko <italic>et al</italic>., [<xref ref-type="bibr" rid="c95">95</xref>] demonstrated lipophilic macrophage-derived factor as a highly active, acute regulator of steroidogenesis, acting through a high capacity StAR-independent pathway.</p>
<p>Alterations in the mitochondrial status affect cell lipid homeostasis and steroid biosynthesis efficiency [<xref ref-type="bibr" rid="c96">96</xref>, <xref ref-type="bibr" rid="c97">97</xref>]. Mitophagy serves as an indispensable mechanism to transfer damaged mitochondria for lysosomal degradation. In LCTs, either mitochondrial function and/or mitophagy can be altered, thus affecting lipid homoeostasis as indirectly shown through perturbations in StAR expression patterns.</p>
<p>It is worth adding that lipids have been recognized as a component of metabolic reprogramming in tumor cells [<xref ref-type="bibr" rid="c98">98</xref>]. Many tumors show a reactivation of <italic>de novo</italic> fatty-acid synthesis for generation of membrane structural lipids; thus, they do not rely on lipids from the bloodstream [<xref ref-type="bibr" rid="c99">99</xref>]. Modulated lipid synthesis may also have a non-cell-autonomous role in cancer development. The growth and metastasis promotion of LCT cannot be excluded with participation of adipocytes [<xref ref-type="bibr" rid="c100">100</xref>]. In addition to their structural and signal transduction roles, lipids can also be broken down into bioactive lipid mediators, regulating a variety of carcinogenic processes including cell growth, cell migration, and metastasis formation, as well as the uptake of chemotherapeutic drugs [<xref ref-type="bibr" rid="c101">101</xref>, <xref ref-type="bibr" rid="c102">102</xref>]. Therefore, based on our results that show alterations in various lipid-controlling molecules, further studies are needed to elucidate the type, role, and regulation of lipids synthesized in tumors of steroidogenic cells. In prostate cancer progression, stimulatory effect of insulin on steroidogenesis was reported [<xref ref-type="bibr" rid="c103">103</xref>].</p>
<p>Enhanced expression of sterol regulatory element binding proteins (SREBPs), involved in cholesterol and fatty acids synthesis through the Akt pathway (anchored-lipid membrane protein), correlates with tumor development, progression, and invasiveness, as well as increased lipid content in cell membranes [<xref ref-type="bibr" rid="c104">104</xref>]. Lipid raft disruption inhibits Akt activation thereby reducing tumor cell proliferation [<xref ref-type="bibr" rid="c105">105</xref>]. The tumor microenvironment has an essential role in the metabolic adaptation of cancer cells [<xref ref-type="bibr" rid="c77">77</xref>]. Through both the post-translational regulation and induction of transcriptional programs, the dysregulated PI3K-Akt-mTOR pathway coordinates the uptake and utilization of multiple nutrients e.g. lipids supporting the enhanced growth and proliferation of cancer cells [<xref ref-type="bibr" rid="c106">106</xref>]. In the testis, blockage of mTOR markedly decreased intracellular testosterone concentration [<xref ref-type="bibr" rid="c106">106</xref>]. In this study, we found PI3K, Akt, and mTOR signaling alterations present in LCTs. It is probable that, in LCTs, an increased phosphorylated and unphosphorylated kinases affect mTOR. The activation of mTOR is possible by other signaling pathway or can be related to advanced LCT development [<xref ref-type="bibr" rid="c107">107</xref>]. Our earlier studies in mouse tumor Leydig cells revealed that GPER and PPAR inhibition activate PI3K and Akt [<xref ref-type="bibr" rid="c52">52</xref>] but mTOR is modulated diversely; inhibits by GPER antagonist alone and together with PPAR&#x03B3; antagonist as well as activates by GPER with PPAR&#x03B1; together and the latter alone (supplementary Fig.7&#x2019;).</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title>Expression of PI3K-Akt-mTOR pathway in human Leydig cell tumor.</title>
<p>(A) Representative blots of qualitative expression of PI3K, Akt, mTOR and (B) relative expression (relative quantification of protein density (ROD); arbitrary units). The relative amount of respective proteins normalized to &#x03B2;-actin. ROD from three separate analyses is expressed as means &#x00B1; SD. Asterisks show significant differences between control and Leydig cell tumor (LCTs). Values are denoted as &#x2217; <italic>p</italic> &#x003C; 0.05. Analysis was performed in triplicate (n &#x003D; 7).</p></caption>
<graphic xlink:href="477901v1_fig7.tif"/>
</fig>
<fig id="fig7a" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title>(supplementary). Effect of GPER and PPAR blockage on expression of mTOR in MA-10 cells</title>
<p>(A) Representative blots of qualitative expression of mTOR and (B) relative expression (relative quantification of protein density (ROD); arbitrary units). The relative amount of protein normalized to &#x03B2;-actin. ROD from three separate analyses is expressed as means &#x00B1; SD. Asterisks show significant differences between control and treated Leydig cells. Values are denoted as &#x2217; <italic>p</italic> &#x003C; 0.05, &#x2217;&#x2217; <italic>p</italic> &#x003C; 0.01 and &#x2217;&#x2217;&#x2217;<italic>p</italic> &#x003C; 0.001. Analysis was performed in triplicate (n &#x003D; 3 for each experimental group).</p></caption>
<graphic xlink:href="477901v1_fig7a.tif"/>
</fig>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8.</label>
<caption><title>Effect of GPER and PPAR blockage on expression on cholesterol content, estradiol secretion and cGMP concentration in MA-10 cells</title>
<p>Cholesterol content (A), estradiol secretion (B) and cGMP concentration (C) in control and treated with GPER (10nM), PPAR&#x03B1; (10&#x00B5;M) and PPAR&#x03B3; (&#x00B5;M) antagonists alone or in combinations for 24h tumor mouse Leydig cells (MA-10). Asterisks show significant differences between control and treated Leydig cells. Values are denoted as &#x2217; <italic>p</italic> &#x003C; 0.05, &#x2217;&#x2217; <italic>p</italic> &#x003C; 0.01 and &#x2217;&#x2217;&#x2217;<italic>p</italic> &#x003C; 0.001. Analysis was performed in triplicate (n &#x003D; 3 for each experimental group).</p></caption>
<graphic xlink:href="477901v1_fig8.tif"/>
</fig>
<p>Distinct changes is cGMP level suggests GPER-PPAR-mediated high or only <italic>via</italic> PPAR low metastatic activity of LCT. Besides antimetastatic strategy with cGMP against in colorectal cancer metastasis cGMP as a mediator of lipolysis in bovine oocytes was confirmed [<xref ref-type="bibr" rid="c108">108</xref>]. In LCTs, cGMP is important in maintaining lipid homeostasis when GPER and PPAR are absent.</p>
<p>The outcome of lipid content modification is a result of protein&#x2013;protein cross-talk between messenger proteins, enzymes, and receptors that regulate pro-oncogenic and apoptotic interactions, including their activity that was revealed here also between GPER-PPAR and HMGCS and HMGCR resulting in overexpression of the latter enzymes that also is in line with our earlier study [<xref ref-type="bibr" rid="c52">52</xref>]. According to Ding <italic>et al</italic>., [<xref ref-type="bibr" rid="c109">109</xref>], HMGCR is an important marker for tumor testis transformation in mice.</p>
<p>Understanding the principles underlying these processes and mechanisms, as well as their relationship, may provide an avenue for controlling cellular lipid balance (through manipulating lipid composition), including managing post-translational modifications of proteins as well as lipid-related gene expression in LCTs [<xref ref-type="bibr" rid="c110">110</xref>].</p>
</sec>
<sec id="s5">
<title>Conclusion</title>
<p>Mechanisms concerning Leydig cell tumorigenesis are scarce, and the role of lipid metabolism in tumor cells has long been disregarded. Recently, however, these mechanisms are recognized as the future of prominent target of therapy (Sreedhar and Zhao 2018). Therefore, alterations in lipid- and cholesterol-associated proteins and mechanisms in LCTs are presented here for the first time.</p>
<p>Our findings shed light on the novel functional interplay between GPER and PPAR ultimately affecting lipid metabolism and steroidogenesis in LCTs. In addition, modifications of LHR, PKA, PLIN, HSL, StAR, TSPO, HMGCS, and HMGCR, together with cGMP and PI3K-Akt-mTOR pathways, may be required in developing innovating approaches (combined with transcriptome/proteome analyses and lipidomic data) that target pathological processes of Leydig cells. There is an urgent need for additional experimental and clinical data to complete the current knowledge on the biology and molecular characteristics of LCTs. Ultimately, this will guide the early diagnostics, treatment, and surveillance of incoming patients with this disease.</p>
</sec>
</body>
<back>
<sec id="s6">
<title>Author contributions</title>
<p>Authors&#x2019; contribution to the work described in the paper: M.K-B., E.G-W., M.K., P.D., A.M., P.P., W.T., B.J. P., A.H. performed research. M.K-B., E.G-W., W.T., A.H., B.B., J.K. W. analyzed the data.</p>
<p>M.K.-B. designed the research study and wrote the paper. All authors have read and approved the final version of the manuscript.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>The Authors are grateful to Grzegorz Kapuscinski, FEBU (urologist) and Robert Wyban, MS (LAB-IVF) (nOvum Fertility Clinic, Warszawa) for cooperation. We thank Dr. Grzegorz Wojtczak (Department of Cell Biology and Imaging, Institute of Zoology and Biomedical Research, Jagiellonian University in Krak&#x00F3;w) for technical help in scanning electron microscopic analyses and to Miss Maja Kudrycka and Miss Patrycja Dutka (Department of Endocrinology) for technical help in qRT-PCR and Western blotting analyses.</p>
</ack>
<sec sec-type="funding">
<title>Financial disclosure statement</title>
<p>This work was supported by a grant OPUS12 2016/23/B/NZ4/01788 (M.K-B) from National Science Centre, Poland.</p>
</sec>
<sec sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that they have no conflict of interest.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Cheville</surname> <given-names>JC</given-names></string-name>. <article-title>Classification and pathology of testicular germ cell and sex cord-stromal tumors</article-title>. <source>Urol Clin North Am</source>. <year>1999</year>; <volume>26</volume>:<fpage>595</fpage>&#x2013;<lpage>609</lpage>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Henderson</surname> <given-names>CG</given-names></string-name>, <string-name><surname>Ahmed</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Sesterhenn</surname> <given-names>I</given-names></string-name>, <string-name><surname>Belman</surname> <given-names>AB</given-names></string-name>, <string-name><surname>Rushton</surname> <given-names>HG</given-names></string-name>. <article-title>Enucleation for prepubertal leydig cell tumor</article-title>. <source>J Urol</source>. <year>2006</year>; <volume>176</volume>: <fpage>703</fpage>&#x2013;<lpage>705</lpage>.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Emerson</surname> <given-names>RE</given-names></string-name>, <string-name><surname>Ulbright</surname> <given-names>TM</given-names></string-name>. <article-title>Morphological approach to tumours of the testis and paratestis</article-title>. <source>J Clin Pathol</source>. <year>2007</year>; <volume>60</volume>: <fpage>866</fpage>&#x2013;<lpage>880</lpage>.</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Farkas</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Sz&#x00E9;kely</surname> <given-names>JG</given-names></string-name>, <string-name><surname>Pusztai</surname> <given-names>C</given-names></string-name>, <string-name><surname>Baki</surname> <given-names>M</given-names></string-name>. <article-title>High frequency of metastatic Leydig cell testicular tumours</article-title>. <source>Oncology</source>. <year>2000</year>; <volume>59</volume>: <fpage>118</fpage>&#x2013;<lpage>121</lpage>.</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Gheorghisan-Galateanu</surname> <given-names>AA</given-names></string-name>. <article-title>Leydig cell tumors of the testis: a case report</article-title>. <source>BMC Res Notes</source>. <year>2014</year>; <volume>7</volume>: <fpage>656</fpage>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Bertram</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Bratloff</surname> <given-names>B</given-names></string-name>, <string-name><surname>Hodges</surname> <given-names>GF</given-names></string-name>, <string-name><surname>Davidson</surname> <given-names>H</given-names></string-name>. <article-title>Treatment of malignant Leydig cell tumor</article-title>. <source>Cancer</source>. <year>1991</year>; <volume>68</volume>, <fpage>2324</fpage>&#x2013;<lpage>2329</lpage>.</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Rich</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Keating</surname> <given-names>MA</given-names></string-name>. <article-title>Leydig cell tumors and tumors associated with congenital adrenal hyperplasia</article-title>. <source>Urol Clin North Am</source>. <year>2000</year>; <volume>27</volume>: <fpage>519</fpage>&#x2013;<lpage>528</lpage>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Gana</surname> <given-names>BM</given-names></string-name>, <string-name><surname>Windsor</surname> <given-names>PM</given-names></string-name>, <string-name><surname>Lang</surname> <given-names>S</given-names></string-name>, <string-name><surname>Macintyre</surname> <given-names>J</given-names></string-name>, <string-name><surname>Baxby</surname> <given-names>K</given-names></string-name>. <article-title>Leydig cell tumor</article-title>. <source>Br J Urol</source>. <year>1995</year>; <volume>75</volume>: <fpage>676</fpage>&#x2013;<lpage>678</lpage>.</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Lai</surname> <given-names>N</given-names></string-name>, <string-name><surname>Zeng</surname> <given-names>X</given-names></string-name>, <string-name><surname>Li</surname> <given-names>M</given-names></string-name>, <string-name><surname>Shu</surname> <given-names>J</given-names></string-name>. <article-title>Leydig cell tumor with lung metastasis diagnosed by lung biopsy</article-title>. <source>Int J Clin Exp Pathol</source>. <year>2015</year>; <volume>8</volume>: <fpage>12972</fpage>&#x2013;<lpage>12976</lpage>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Laguna</surname> <given-names>MP</given-names></string-name>, <string-name><surname>Nicolai</surname> <given-names>N</given-names></string-name>, <string-name><surname>Oldenburg</surname> <given-names>J</given-names></string-name>; <article-title>European Association of Urology. Guidelines on Testicular Cancer: 2015 Update</article-title>. <source>Eur Urol</source>. <year>2015</year>; <volume>68</volume>:<fpage>1054</fpage>&#x2013;<lpage>1068</lpage>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Lejeune</surname> <given-names>H</given-names></string-name>, <string-name><surname>Habert</surname> <given-names>R</given-names></string-name>, <string-name><surname>Saez</surname> <given-names>JM</given-names></string-name>. <article-title>Origin, proliferation and differentiation of Leydig cells</article-title>. <source>J Mol Endocrinol</source>. <year>1998</year>; <volume>20</volume>: <fpage>1</fpage>&#x2013;<lpage>25</lpage>.</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Huang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Song</surname> <given-names>J</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>M</given-names></string-name>, <string-name><surname>Zan</surname> <given-names>Q</given-names></string-name>. <article-title>Primary Leydig cell tumour of epididymis: a rare case report with review of literature</article-title>. <source>Andrologia</source>. <year>2013</year>; <volume>45</volume>: <fpage>430</fpage>&#x2013;<lpage>433</lpage>.</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Hekimgil</surname> <given-names>M</given-names></string-name>, <string-name><surname>Altay</surname> <given-names>B</given-names></string-name>, <string-name><surname>Yakut</surname> <given-names>BD</given-names></string-name>, <string-name><surname>Soydan</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ozyurt</surname> <given-names>C</given-names></string-name>, <string-name><surname>Killi</surname> <given-names>R</given-names></string-name>. <article-title>Leydig cell tumor of the testis: comparison of histopathological and immunohistochemical features of three azoospermic cases and one malignant case</article-title>. <source>Pathol Int</source>. <year>2001</year>; <volume>51</volume>: <fpage>792</fpage>&#x2013;<lpage>796</lpage>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Kim</surname> <given-names>I</given-names></string-name>, <string-name><surname>Young</surname> <given-names>RH</given-names></string-name>, <string-name><surname>Scully</surname> <given-names>RE</given-names></string-name>. <article-title>Leydig cell tumors of the testis. A clinicopathological analysis of 40 cases and review of the literature</article-title>. <source>Am J Surg Pathol</source>. <year>1985</year>; <volume>3</volume>: <fpage>177</fpage>&#x2013;<lpage>192</lpage>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Tiwari</surname> <given-names>P</given-names></string-name>, <string-name><surname>Goel</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sharma</surname> <given-names>P</given-names></string-name>, <string-name><surname>Kumar</surname> <given-names>S</given-names></string-name>, <string-name><surname>Vijay</surname> <given-names>M</given-names></string-name>, <string-name><surname>Dutta</surname> <given-names>A</given-names></string-name>. <article-title>Leydig cell tumor with mediastinal and lung metastasis</article-title>. <source>Saudi J Kidney Dis Transpl.</source> <year>2011</year>; <volume>22</volume>: <fpage>354</fpage>&#x2013;<lpage>356</lpage>.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Bozzini</surname> <given-names>G</given-names></string-name>, <string-name><surname>Ratti</surname> <given-names>D</given-names></string-name>, <string-name><surname>Carmignani</surname> <given-names>L</given-names></string-name>; <article-title>en representaci&#x00F3;n de Young Academic Urologists (YAU) Men's Health Group. Treatment of leydig cell tumours of the testis: Can testis-sparing surgery replace radicalorchidectomy? Results of a systematic review</article-title>. <source>Actas Urol Esp</source>. <year>2017</year>; <volume>41</volume>, <fpage>146</fpage>&#x2013;<lpage>154</lpage>.</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Giacaglia</surname> <given-names>LR</given-names></string-name>, <string-name><surname>Kohek</surname> <given-names>MB</given-names></string-name> <string-name><surname>da</surname> <given-names>F</given-names></string-name>, <string-name><surname>Carvalho</surname> <given-names>FM</given-names></string-name>, <string-name><surname>Fragoso</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Mendonca</surname> <given-names>B</given-names></string-name>, <string-name><surname>Latronico</surname> <given-names>AC</given-names></string-name>. <article-title>No evidence of somatic activating mutations on gonadotropin receptor genes in sex cord stromal tumors</article-title>. <source>Fertil Steril</source>; <year>2000</year>; <volume>74</volume>: <fpage>992</fpage>&#x2013;<lpage>995</lpage>.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Carvajal-Carmona</surname> <given-names>LG</given-names></string-name>, <string-name><surname>Alam</surname> <given-names>NA</given-names></string-name>, <string-name><surname>Pollard</surname> <given-names>PJ</given-names></string-name>, <string-name><surname>Jones</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Barclay</surname> <given-names>E</given-names></string-name>, <string-name><surname>Wortham</surname> <given-names>N</given-names></string-name>, <etal>et al.</etal>, <article-title>Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2006</year>; <volume>91</volume>, <fpage>3071</fpage>&#x2013;<lpage>3075</lpage>.</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Skakkebaek</surname> <given-names>NE</given-names></string-name>, <string-name><surname>Rajpert-De Meyts</surname> <given-names>E</given-names></string-name>, <string-name><surname>Main</surname> <given-names>KM</given-names></string-name>. <article-title>Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects</article-title>. <source>Hum Reprod</source>. <year>2001</year>; <volume>5</volume>: <fpage>972</fpage>&#x2013;<lpage>978</lpage>.</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Joensen</surname> <given-names>UN</given-names></string-name>, <string-name><surname>J&#x00F8;rgensen</surname> <given-names>N</given-names></string-name>, <string-name><surname>Rajpert-De Meyts</surname> <given-names>E</given-names></string-name>, <string-name><surname>Skakkebaek</surname> <given-names>NE</given-names></string-name>. <article-title>Testicular dysgenesis syndrome and Leydig cell function</article-title>. <source>Basic Clin Pharmacol Toxicol</source>. <year>2008</year>; <volume>102</volume>: <fpage>155</fpage>&#x2013;<lpage>161</lpage>.</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Holm</surname> <given-names>M</given-names></string-name>, <string-name><surname>Rajpert-De Meyts</surname> <given-names>E</given-names></string-name>, <string-name><surname>Andersson</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Skakkebaek</surname> <given-names>NE</given-names></string-name>. <article-title>Leydig cell micronodules are a common finding in testicular biopsies from men with impaired spermatogenesis and are associated with decreased testosterone/LH ratio</article-title>. <source>J Pathol</source>. <year>2003</year>; <volume>199</volume>: <fpage>378</fpage>&#x2013;<lpage>386</lpage>.</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Ho</surname> <given-names>GT</given-names></string-name>, <string-name><surname>Gardner</surname> <given-names>H</given-names></string-name>, <string-name><surname>Mostofi</surname> <given-names>K</given-names></string-name>, <string-name><surname>DeWolf</surname> <given-names>WC</given-names></string-name>, <string-name><surname>Loughlin</surname> <given-names>KR</given-names></string-name>, <string-name><surname>Morgentaler</surname> <given-names>A</given-names></string-name>. <article-title>The effect of testicular nongerm cell tumors on local spermatogenesis</article-title>. <source>Fertil Steril.</source> <year>1994</year>; <volume>62</volume>: <fpage>162</fpage>&#x2013;<lpage>166</lpage>.</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Lardone</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Piottante</surname> <given-names>A</given-names></string-name>, <string-name><surname>Valdevenito</surname> <given-names>R</given-names></string-name>, <string-name><surname>Ebensperger</surname> <given-names>M</given-names></string-name>, <string-name><surname>Castro</surname> <given-names>A</given-names></string-name>. <article-title>Histological and hormonal testicular function in oligo/azoospermic infertile men</article-title>. <source>Andrologia</source>. <year>2013</year>; <volume>45</volume>, <fpage>379</fpage>&#x2013;<lpage>385</lpage>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Kozina</surname> <given-names>V</given-names></string-name>, <string-name><surname>Geist</surname> <given-names>D</given-names></string-name>, <string-name><surname>Kubinov&#x00E1;</surname> <given-names>L</given-names></string-name>, <string-name><surname>Bili&#x0107;</surname> <given-names>E</given-names></string-name>, <string-name><surname>Karnthaler</surname> <given-names>HP</given-names></string-name>, <string-name><surname>Waitz</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal>, <article-title>Visualization of Reinke's crystals in normal and cryptorchid testis</article-title>. <source>Histochem Cell Biol</source>. <year>2011</year>; <volume>135</volume>: <fpage>215</fpage>&#x2013;<lpage>228</lpage>.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Soerensen</surname> <given-names>RR</given-names></string-name>, <string-name><surname>Johannsen</surname> <given-names>TH</given-names></string-name>, <string-name><surname>Skakkebaek</surname> <given-names>NE</given-names></string-name>, <string-name><surname>Rajpert-De Meyts</surname> <given-names>E</given-names></string-name>. <article-title>Leydig cell clustering and Reinke crystal distribution in relation to hormonal function in adult patients with testicular dysgenesis syndrome (TDS) including cryptorchidism</article-title>. <source>Hormones (Athens)</source>. <year>2016</year>; <volume>15</volume>: <fpage>518</fpage>&#x2013;<lpage>526</lpage>.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Paniagua</surname> <given-names>R</given-names></string-name>, <string-name><surname>Nistal</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bravo</surname> <given-names>MP</given-names></string-name>. <article-title>Leydig cell types in primary testicular disorders</article-title>. <source>Hum Pathol.</source> <year>1984</year>; <volume>15</volume>: <fpage>181</fpage>&#x2013;<lpage>190</lpage>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Zimmerli</surname> <given-names>UU</given-names></string-name>, <string-name><surname>Hedinger</surname> <given-names>CE</given-names></string-name>. <article-title>Hyperplasia and hypertrophy of Leydig cells associated with testicular germ cell tumours containing syncytiotrophoblastic giant cells</article-title>. <source>Virchows Arch A Pathol Anat Histopathol.</source> <year>1991</year>; <volume>419</volume>: <fpage>469</fpage>&#x2013;<lpage>474</lpage>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Dirami</surname> <given-names>G</given-names></string-name>, <string-name><surname>Teerds</surname> <given-names>KJ</given-names></string-name>, <string-name><surname>Cooke</surname> <given-names>BA</given-names></string-name>. <article-title>Effect of a dopamine agonist on the development of Leydig cell hyperplasia in Sprague-Dawley rats</article-title>. <source>Toxicol Appl Pharmacol</source>. <year>1996</year>; <volume>141</volume>, <fpage>169</fpage>&#x2013;<lpage>177</lpage>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="other"><string-name><surname>Greaves</surname> <given-names>P</given-names></string-name>. <article-title>Histopathology of preclinical toxicity studies : interpretation and relevance in drug safety evaluation</article-title>. <edition>4th</edition> ed. <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier AP</publisher-name>. <year>2012</year>; p.<fpage>1</fpage>&#x2013;<lpage>867</lpage>.</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Cook</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Klinefelter</surname> <given-names>GR</given-names></string-name>, <string-name><surname>Hardisty</surname> <given-names>JF</given-names></string-name>, <string-name><surname>Sharpe</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Foster</surname> <given-names>PM</given-names></string-name>. <article-title>Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms, and relevance to humans</article-title>. <source>Crit Rev Toxicol.</source> <year>1999</year>; <volume>2</volume>: <fpage>169</fpage>&#x2013;<lpage>261</lpage>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Gould</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Hurst</surname> <given-names>PR</given-names></string-name>, <string-name><surname>Nicholson</surname> <given-names>HD</given-names></string-name>. <article-title>The effects of oestrogen receptors alpha and beta on testicular cell number and steroidogenesis in mice</article-title>. <source>Reproduction.</source> <year>2007</year>; <volume>134</volume>: <fpage>271</fpage>&#x2013;<lpage>279</lpage>.</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Kotula-Balak</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hejmej</surname> <given-names>A</given-names></string-name>, <string-name><surname>Kopera</surname> <given-names>I</given-names></string-name>, <string-name><surname>Lydka</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bilinska</surname> <given-names>B</given-names></string-name>. <article-title>Prenatal and neonatal exposure to flutamide affects function of Leydig cells in adult boar</article-title>. <source>Domest Anim Endocrinol</source>. <year>2012</year>; <volume>42</volume>: <fpage>142</fpage>&#x2013;<lpage>154</lpage>.</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Pawlicki</surname> <given-names>P</given-names></string-name>, <string-name><surname>Milon</surname> <given-names>A</given-names></string-name>, <string-name><surname>Zarzycka</surname> <given-names>M</given-names></string-name>, <string-name><surname>Galas</surname> <given-names>J</given-names></string-name>, <string-name><surname>Tworzydlo</surname> <given-names>W</given-names></string-name>, <string-name><surname>Kaminska</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal>, <article-title>Does signaling of estrogen-related receptors affect structure and function of bank vole Leydig cells?</article-title> <source>J Physiol Pharmacol</source>. <year>2017</year>; <volume>68</volume>: <fpage>459</fpage>&#x2013;<lpage>476</lpage>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Tazi</surname> <given-names>MF</given-names></string-name>, <string-name><surname>Mellas</surname> <given-names>S</given-names></string-name>, <string-name><surname>El Fassi</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Farih</surname> <given-names>MH</given-names></string-name>. <article-title>Leydig cell hyperplasia revealed by gynecomastia</article-title>. <source>Rev Urol</source>. <year>2008</year>; <volume>10</volume>: <fpage>164</fpage>&#x2013;<lpage>167</lpage>.</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Carpino</surname> <given-names>A</given-names></string-name>, <string-name><surname>Rago</surname> <given-names>V</given-names></string-name>, <string-name><surname>Pezzi</surname> <given-names>V</given-names></string-name>, <string-name><surname>Carani</surname> <given-names>C</given-names></string-name>, <string-name><surname>And&#x00F2;</surname> <given-names>S</given-names></string-name>. <article-title>Detection of aromatase and estrogen receptors (ERalpha, ERbeta1, ERbeta2) in human Leydig cell tumor</article-title>. <source>Eur J Endocrinol</source>. <year>2007</year>; <volume>2</volume>: <fpage>239</fpage>&#x2013;<lpage>244</lpage>.</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Chimento</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sirianni</surname> <given-names>R</given-names></string-name>, <string-name><surname>Casaburi</surname> <given-names>I</given-names></string-name>, <string-name><surname>Pezzi</surname> <given-names>V</given-names></string-name>. <article-title>GPER Signaling in Spermatogenesis and Testicular Tumors</article-title>. <source>Front Endocrinol (Lausanne)</source>. <year>2014</year>; <volume>6</volume>: <fpage>30</fpage>.</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Kotula-Balak</surname> <given-names>M</given-names></string-name>, <string-name><surname>Milon</surname> <given-names>A</given-names></string-name>, <string-name><surname>Pawlicki</surname> <given-names>P</given-names></string-name>, <string-name><surname>Opydo-Chanek</surname> <given-names>M</given-names></string-name>, <string-name><surname>Galas</surname> <given-names>J</given-names></string-name>, <string-name><surname>Pacwa</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal>, <article-title>Diverse role of estrogen-related receptors &#x03B1;, &#x03B2; and &#x03B3; in biology of tumor Leydig cell</article-title>. <source>Tissue Cell</source>. <year>2018</year>a; <volume>52</volume>: <fpage>78</fpage>&#x2013;<lpage>91</lpage>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Fietz</surname> <given-names>D</given-names></string-name>, <string-name><surname>Ratzenb&#x00F6;ck</surname> <given-names>C</given-names></string-name>, <string-name><surname>Hartmann</surname> <given-names>K</given-names></string-name>, <string-name><surname>Raabe</surname> <given-names>O</given-names></string-name>, <string-name><surname>Kliesch</surname> <given-names>S</given-names></string-name>, <string-name><surname>Weidner</surname> <given-names>W</given-names></string-name>, <string-name><surname>Klug</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bergmann</surname> <given-names>M</given-names></string-name>. <article-title>Expression pattern of estrogen receptors &#x03B1; and &#x03B2; and G-protein-coupled estrogen receptor 1 in the human testis</article-title>. <source>Histochem Cell Biol</source>. <year>2014</year>; <volume>142</volume>: <fpage>421</fpage>&#x2013;<lpage>432</lpage>.</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Fietz</surname> <given-names>D</given-names></string-name>, <string-name><surname>Bergmann</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hartmann</surname> <given-names>K</given-names></string-name>. <article-title>In Situ Hybridization of Estrogen Receptors &#x03B1; and &#x03B2; and GPER in the Human Testis</article-title>. <source>Methods Mol Biol.</source> <year>2016</year>; <volume>1366</volume>: <fpage>189</fpage>&#x2013;<lpage>205</lpage>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Levin</surname> <given-names>ER</given-names></string-name>. <article-title>Minireview: extranuclear steroid receptors: roles in modulation of cell functions</article-title>. <source>Mol Endocrinol</source>. <year>2011</year>; <volume>25</volume>: <fpage>377</fpage>&#x2013;<lpage>384</lpage>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Schmidt</surname> <given-names>A</given-names></string-name>, <string-name><surname>Endo</surname> <given-names>N</given-names></string-name>, <string-name><surname>Rutledge</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Vogel</surname> <given-names>R</given-names></string-name>, <string-name><surname>Shinar</surname> <given-names>D</given-names></string-name>, <string-name><surname>Rodan</surname> <given-names>GA</given-names></string-name>. <article-title>Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids</article-title>. <source>Mol Endocrinol</source>. <year>1992</year>; <volume>6</volume>: <fpage>1634</fpage>&#x2013;<lpage>1641</lpage>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Braissant</surname> <given-names>O</given-names></string-name>, <string-name><surname>Foufelle</surname> <given-names>F</given-names></string-name>, <string-name><surname>Scotto</surname> <given-names>C</given-names></string-name>, <string-name><surname>Dau&#x00E7;a</surname> <given-names>M</given-names></string-name>, <string-name><surname>Wahli</surname> <given-names>W</given-names></string-name>. <article-title>Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, - beta, and -gamma in the adult rat</article-title>. <source>Endocrinology</source>. <year>1996</year>; <volume>137</volume>: <fpage>354</fpage>&#x2013;<lpage>366</lpage>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Harada</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Tanaka</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ichikawa</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kamijo</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Sugiyama</surname> <given-names>E</given-names></string-name>, <string-name><surname>Gonzalez</surname> <given-names>FJ</given-names></string-name>, <etal>et al.</etal>, <article-title>PPAR&#x03B1;- dependent cholesterol/testosterone disruption in Leydig cells mediates 2,4- dichlorophenoxyacetic acid-induced testicular toxicity in mice</article-title>. <source>Arch Toxicol</source>. <year>2016</year>; <volume>90</volume>: <fpage>3061</fpage>&#x2013;<lpage>3071</lpage>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Biegel</surname> <given-names>LB</given-names></string-name>, <string-name><surname>Hurtt</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Frame</surname> <given-names>SR</given-names></string-name>, <string-name><surname>O'Connor</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Cook</surname> <given-names>JC</given-names></string-name>. <article-title>Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats</article-title>. <source>Toxicol Sci</source>. <year>2001</year>; <volume>1</volume>: <fpage>44</fpage>&#x2013;<lpage>55</lpage>.</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Hess</surname> <given-names>RA</given-names></string-name>. <article-title>Estrogen in the adult male reproductive tract: A review</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2003</year>; <volume>1</volume>: <fpage>52</fpage>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Maris</surname> <given-names>P</given-names></string-name>, <string-name><surname>Campana</surname> <given-names>A</given-names></string-name>, <string-name><surname>Barone</surname> <given-names>I</given-names></string-name>, <string-name><surname>Giordano</surname> <given-names>C</given-names></string-name>, <string-name><surname>Morelli</surname> <given-names>C</given-names></string-name>, <string-name><surname>Malivindi</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal>, <article-title>Androgens inhibit aromatase expression through DAX-1: insights into the molecular link between hormone balance and Leydig cancer development</article-title>. <source>Endocrinology</source>. <year>2015</year>; <volume>4</volume>: <fpage>1251</fpage>&#x2013;<lpage>1262</lpage>.</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Seyfried</surname> <given-names>TN</given-names></string-name>, <string-name><surname>Shelton</surname> <given-names>LM</given-names></string-name>. <article-title>Cancer as a metabolic disease</article-title>. <source>Nutr Metab</source>. <year>2010</year>; <volume>27</volume>: <fpage>7</fpage>.</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Miller</surname> <given-names>WL</given-names></string-name>. <article-title>A brief history of adrenal research: steroidogenesis - the soul of the adrenal</article-title>. <source>Mol Cell Endocrinol</source>. <year>2013</year>; <volume>22</volume>: <fpage>5</fpage>&#x2013;<lpage>14</lpage>.</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname> <given-names>TF</given-names></string-name>, <string-name><surname>Tang</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Li</surname> <given-names>PS</given-names></string-name>, <string-name><surname>Shen</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Li</surname> <given-names>JG</given-names></string-name>, <string-name><surname>Miao</surname> <given-names>HH</given-names></string-name>, <string-name><surname>Li</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Song</surname> <given-names>BL</given-names></string-name>. <article-title>Ablation of gp78 in liver improves hyperlipidemia and insulin resistance by inhibiting SREBP to decrease lipid biosynthesis</article-title>. <source>Cell Metab.</source> <year>2012</year>; <volume>8</volume>: <fpage>213</fpage>&#x2013;<lpage>225</lpage>.</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Ascoli</surname> <given-names>M</given-names></string-name>. <article-title>Characterization of several clonal lines of cultured Leydig tumor cells: gonadotropin receptors and steroidogenic responses</article-title>. <source>Endocrinology</source>. <year>1981</year>; <volume>108</volume>: <fpage>88</fpage>&#x2013;<lpage>95</lpage>.</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Gorowska-Wojtowicz</surname> <given-names>E</given-names></string-name>, <string-name><surname>Dutka</surname> <given-names>P</given-names></string-name>, <string-name><surname>Kudrycka</surname> <given-names>M</given-names></string-name>, <string-name><surname>Pawlicki</surname> <given-names>P</given-names></string-name>, <string-name><surname>Milon</surname> <given-names>A</given-names></string-name>, <string-name><surname>Plachno</surname> <given-names>B.J</given-names></string-name>, <etal>et al.</etal>, <article-title>Regulation of steroidogenic function of mouse Leydig cells: G-coupled membrane estrogen receptor and peroxisome proliferator-activated receptor partnership</article-title>. <source>J Physiol Pharmacol</source>. <year>2018</year>; <volume>69</volume>: <fpage>xx</fpage>&#x2013;<lpage>xx</lpage>.</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Kotula-Balak</surname> <given-names>M</given-names></string-name>, <string-name><surname>Chojnacka</surname> <given-names>K</given-names></string-name>, <string-name><surname>Hejmej</surname> <given-names>A</given-names></string-name>, <string-name><surname>Galas</surname> <given-names>J</given-names></string-name>, <string-name><surname>Satola</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bilinska</surname> <given-names>B</given-names></string-name>. <article-title>Does 4-tert-octylphenol affect estrogen signaling pathways in bank vole Leydig cells and tumor mouse Leydig cells in vitro?</article-title> <source>Reprod Toxicol</source>. <year>2013</year>; <volume>39</volume>: <fpage>6</fpage>&#x2013;<lpage>16</lpage>.</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="other"><string-name><surname>Kotula-Balak</surname> <given-names>M</given-names></string-name>, <string-name><surname>Pawlicki</surname> <given-names>P</given-names></string-name>, <string-name><surname>Milon</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tworzydlo</surname> <given-names>W</given-names></string-name>, <string-name><surname>Sekula</surname> <given-names>M</given-names></string-name>, <string-name><surname>Pacwa</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal>, <article-title>The role of G-protein-coupled membrane estrogen receptor in mouse Leydig cell function-in vivo and in vitro evaluation</article-title>. <source>Cell Tissue Res</source> <year>2018b</year>, doi: <pub-id pub-id-type="doi">10.1007/s00441-018-2861-7</pub-id>.</mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="other"><string-name><surname>Smolen</surname> <given-names>AJ</given-names></string-name>. <article-title>Image analytic techniques for quantification of immunocytochemical staining in the nervous system</article-title>. <source>Conn PM</source>. (Ed.), <publisher-name>Methods Neurosci Acad Press</publisher-name>, <publisher-loc>San Diego</publisher-loc> <year>1999</year>; pp. <fpage>208</fpage>&#x2013;<lpage>229</lpage>.</mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Al-Agha</surname> <given-names>OM</given-names></string-name>, <string-name><surname>Axiotis</surname> <given-names>CA</given-names></string-name>. <article-title>An in-depth look at Leydig cell tumor of the testis</article-title>. <source>Arch Pathol Lab Med</source>. <year>2007</year>; <volume>131</volume>: <fpage>311</fpage>&#x2013;<lpage>317</lpage>.</mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Richmond</surname> <given-names>I</given-names></string-name>, <string-name><surname>Banerjee</surname> <given-names>SS</given-names></string-name>, <string-name><surname>Eyden</surname> <given-names>BP</given-names></string-name>, <string-name><surname>Sissons</surname> <given-names>MC</given-names></string-name>. <article-title>Sarcomatoid Leydig cell tumor of the testis</article-title>. <source>Histopathology</source>. <year>1995</year>; <volume>27</volume>: <fpage>578</fpage>&#x2013;<lpage>580</lpage>.</mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="other"><string-name><surname>Ghadially</surname> <given-names>FN</given-names></string-name>. <article-title>Ultrastructural Pathology of the Cell and Matrix</article-title>. <edition>4th</edition> ed. <publisher-name>Boston, Mass</publisher-name>: <publisher-loc>Butterworth-Heinemann</publisher-loc>; <year>1997</year>.</mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Carreau</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wolczynski</surname> <given-names>S</given-names></string-name>, <string-name><surname>Galeraud-Denis</surname> <given-names>I</given-names></string-name>. <article-title>Aromatase, oestrogens and human male reproduction</article-title>. <source>Philos Trans R Soc Lond B Biol Sci</source>. <year>2010</year>; <volume>365</volume>: <fpage>1571</fpage>&#x2013;<lpage>1579</lpage>.</mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Sirianni</surname> <given-names>R</given-names></string-name>, <string-name><surname>Chimento</surname> <given-names>A</given-names></string-name>, <string-name><surname>Malivindi</surname> <given-names>R</given-names></string-name>, <string-name><surname>Mazzitelli</surname> <given-names>I</given-names></string-name>, <string-name><surname>And&#x00F2;</surname> <given-names>S</given-names></string-name>, <string-name><surname>Pezzi</surname> <given-names>V</given-names></string-name>. <article-title>Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation</article-title>. <source>Cancer Res</source>. <year>2007</year>; <volume>67</volume>: <fpage>8368</fpage>&#x2013;<lpage>8377</lpage>.</mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Fowler</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Gill</surname> <given-names>K</given-names></string-name>, <string-name><surname>Kirma</surname> <given-names>N</given-names></string-name>, <string-name><surname>Dillehay</surname> <given-names>DL</given-names></string-name>, <string-name><surname>Tekmal</surname> <given-names>RR</given-names></string-name>. <article-title>Overexpression of aromatase leads to development of testicular leydig cell tumors: an in vivo model for hormone-mediated testicular cancer</article-title>. <source>Am J Pathol</source>. <year>2000</year>; <volume>156</volume>: <fpage>347</fpage>&#x2013;<lpage>353</lpage>.</mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>Chimento</surname> <given-names>A</given-names></string-name>, <string-name><surname>Casaburi</surname> <given-names>I</given-names></string-name>, <string-name><surname>Bartucci</surname> <given-names>M</given-names></string-name>, <string-name><surname>Patrizii</surname> <given-names>M</given-names></string-name>, <string-name><surname>Dattilo</surname> <given-names>R</given-names></string-name>, <string-name><surname>Avena</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal>, <article-title>Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells</article-title>. <source>Cell Death Dis</source>. <year>2011</year>; <volume>1</volume>: <issue>4</issue>:<fpage>e747</fpage>.</mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="journal"><string-name><surname>Rago</surname> <given-names>V</given-names></string-name>, <string-name><surname>Romeo</surname> <given-names>F</given-names></string-name>, <string-name><surname>Giordano</surname> <given-names>F</given-names></string-name>, <string-name><surname>Ferraro</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ando</surname> <given-names>S</given-names></string-name>, <string-name><surname>Carpino</surname> <given-names>A</given-names></string-name>. <article-title>Identification of ERbeta1 and ERbeta2 in human seminoma, in embryonal carcinoma and in their adjacent intratubular germ cell neoplasia</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2009</year>; <volume>7</volume>:<fpage>56</fpage>. <pub-id pub-id-type="doi">10.1186/1477-7827-7-56</pub-id>.</mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><string-name><surname>Rago</surname> <given-names>V</given-names></string-name>, <string-name><surname>Romeo</surname> <given-names>F</given-names></string-name>, <string-name><surname>Giordano</surname> <given-names>F</given-names></string-name>, <string-name><surname>Maggiolini</surname> <given-names>M</given-names></string-name>, <string-name><surname>Carpino</surname> <given-names>A</given-names></string-name>. <article-title>Identification of the estrogen receptor GPER in neoplastic and non-neoplastic human testes</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2011</year>; <volume>9</volume>:<fpage>135</fpage>. <pub-id pub-id-type="doi">10.1186/1477-7827-9-135</pub-id>.</mixed-citation></ref>
<ref id="c65"><label>65.</label><mixed-citation publication-type="journal"><string-name><surname>Salerno</surname> <given-names>M</given-names></string-name>, <string-name><surname>Cascio</surname> <given-names>O</given-names></string-name>, <string-name><surname>Bertozzi</surname> <given-names>G</given-names></string-name>, <string-name><surname>Sessa</surname> <given-names>F</given-names></string-name>, <string-name><surname>Messina</surname> <given-names>A</given-names></string-name>, <string-name><surname>Monda</surname> <given-names>V</given-names></string-name>, <etal>et al.</etal>, <article-title>Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review</article-title>. <source>Oncotarget</source>. <year>2018</year>; <volume>10</volume>: <fpage>19415</fpage>&#x2013;<lpage>19426</lpage>.</mixed-citation></ref>
<ref id="c66"><label>66.</label><mixed-citation publication-type="journal"><string-name><surname>Altieri</surname> <given-names>VM</given-names></string-name>, <string-name><surname>Altieri</surname> <given-names>B</given-names></string-name>, <string-name><surname>Castellucci</surname> <given-names>R</given-names></string-name>, <string-name><surname>Alba</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bottone</surname> <given-names>F</given-names></string-name>, <string-name><surname>Fragal&#x00E0;</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal>, <article-title>Leydig cell tumour and giant adrenal myelolipoma associated with adrenogenital syndrome: a case report with a review of the literature</article-title>. <source>Urologia</source>. <year>2016</year>; <volume>83</volume>: <fpage>43</fpage>&#x2013;<lpage>48</lpage>.</mixed-citation></ref>
<ref id="c67"><label>67.</label><mixed-citation publication-type="other"><string-name><surname>BOOmIan</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Eustis</surname> <given-names>SL</given-names></string-name>, <string-name><surname>Elwell</surname> <given-names>MR</given-names></string-name>, <string-name><surname>Montgomery</surname> <given-names>CA</given-names></string-name>, <string-name><surname>MacKenzie</surname> <given-names>WF</given-names></string-name>, (eds.) <article-title>Pathology of the Fischer rat: Reference and atlas</article-title>. <publisher-loc>San Diego</publisher-loc>: <publisher-name>Academic Press</publisher-name>; <year>1990</year>.</mixed-citation></ref>
<ref id="c68"><label>68.</label><mixed-citation publication-type="other"><string-name><surname>McConnell</surname> <given-names>RF</given-names></string-name>, <string-name><surname>Westen</surname> <given-names>HH</given-names></string-name>, <string-name><surname>Ulland</surname> <given-names>BM</given-names></string-name>, <string-name><surname>Bosland</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Ward</surname> <given-names>JM</given-names></string-name>. <article-title>Proliferative lesions of the testes in rats with selected examples from mice</article-title>. <source>URG-3, Guides for toxicologic pathology, STP/ARP/AFIP, Washington</source>; <year>1992</year>.</mixed-citation></ref>
<ref id="c69"><label>69.</label><mixed-citation publication-type="journal"><string-name><surname>Clegg</surname> <given-names>ED</given-names></string-name>, <string-name><surname>Cook</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Chapin</surname> <given-names>RE</given-names></string-name>, <string-name><surname>Foster</surname> <given-names>PM</given-names></string-name>, <string-name><surname>Daston</surname> <given-names>GP</given-names></string-name>. <article-title>Leydig cell hyperplasia and adenoma formation: mechanisms and relevance to humans</article-title>. <source>Reprod Toxicol.</source> <year>1997</year>; <volume>11</volume>: <fpage>107</fpage>&#x2013;<lpage>121</lpage>.</mixed-citation></ref>
<ref id="c70"><label>70.</label><mixed-citation publication-type="journal"><string-name><surname>Rasoulpour</surname> <given-names>RJ</given-names></string-name>, <string-name><surname>Terry</surname> <given-names>C</given-names></string-name>, <string-name><surname>LeBaron</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Stebbins</surname> <given-names>K</given-names></string-name>, <string-name><surname>Ellis-Hutchings</surname> <given-names>RG</given-names></string-name>, <string-name><surname>Billington</surname> <given-names>R</given-names></string-name>. <article-title>Mode-of-action and human relevance framework analysis for rat Leydig cell tumors associated with sulfoxaflor</article-title>. <source>Crit Rev Toxicol</source>. <year>2014</year>; <volume>2</volume>: <fpage>25</fpage>&#x2013;<lpage>44</lpage>.</mixed-citation></ref>
<ref id="c71"><label>71.</label><mixed-citation publication-type="journal"><string-name><surname>Aoyama</surname> <given-names>T</given-names></string-name>, <string-name><surname>Peters</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Iritani</surname> <given-names>N</given-names></string-name>, <string-name><surname>Nakajima</surname> <given-names>T</given-names></string-name>, <string-name><surname>Furihata</surname> <given-names>K</given-names></string-name>, <string-name><surname>Hashimoto</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal>, <article-title>Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisomeproliferator-activated receptor alpha (PPARalpha)</article-title>. <source>J Biol Chem</source>. <year>1998</year>; <volume>273</volume>: <fpage>5678</fpage>&#x2013;<lpage>5684</lpage>.</mixed-citation></ref>
<ref id="c72"><label>72.</label><mixed-citation publication-type="journal"><string-name><surname>Watanabe</surname> <given-names>K</given-names></string-name>, <string-name><surname>Fujii</surname> <given-names>H</given-names></string-name>, <string-name><surname>Takahashi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kodama</surname> <given-names>M</given-names></string-name>, <string-name><surname>Aizawa</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ohta</surname> <given-names>Y</given-names></string-name>, <etal>et al.</etal>, <article-title>Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity</article-title>. <source>J Biol Chem</source>. <year>2000</year>; <volume>29</volume>: <fpage>22293</fpage>&#x2013;<lpage>22299</lpage>.</mixed-citation></ref>
<ref id="c73"><label>73.</label><mixed-citation publication-type="journal"><string-name><surname>Kamijo</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Hora</surname> <given-names>K</given-names></string-name>, <string-name><surname>Tanaka</surname> <given-names>N</given-names></string-name>, <string-name><surname>Usuda</surname> <given-names>N</given-names></string-name>, <string-name><surname>Kiyosawa</surname> <given-names>K</given-names></string-name>, <string-name><surname>Nakajima</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal>, <article-title>Identification of functions of peroxisome proliferator-activated receptor alpha in proximal tubules</article-title>. <source>J Am Soc Nephrol</source>. <year>2002</year>; <volume>13</volume>: <fpage>1691</fpage>&#x2013;<lpage>1702</lpage>.</mixed-citation></ref>
<ref id="c74"><label>74.</label><mixed-citation publication-type="journal"><string-name><surname>Hase</surname> <given-names>T</given-names></string-name>, <string-name><surname>Yoshimura</surname> <given-names>R</given-names></string-name>, <string-name><surname>Mitsuhashi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Segawa</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Kawahito</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Wada</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal>, <article-title>Expression of peroxisome proliferator-activated receptors in human testicular cancer and growthinhibition by its agonists</article-title>. <source>Urology</source>. <year>2002</year>; <volume>60</volume>: <fpage>542</fpage>&#x2013;<lpage>547</lpage>.</mixed-citation></ref>
<ref id="c75"><label>75.</label><mixed-citation publication-type="journal"><string-name><surname>Sozmen</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kabak</surname> <given-names>YB</given-names></string-name>, <string-name><surname>Gulbahar</surname> <given-names>MY</given-names></string-name>, <string-name><surname>Gacar</surname> <given-names>A</given-names></string-name>, <string-name><surname>Karayigit</surname> <given-names>MO</given-names></string-name>, <string-name><surname>Guvenc</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal>, <article-title>Immunohistochemical characterization of peroxisome proliferator-activated receptors in canine normal testis and testicular tumours</article-title>. <source>J Comp Pathol</source>. <year>2013</year>; <volume>149</volume>: <fpage>10</fpage>&#x2013;<lpage>18</lpage>.</mixed-citation></ref>
<ref id="c76"><label>76.</label><mixed-citation publication-type="journal"><string-name><surname>Kadivar</surname> <given-names>A</given-names></string-name>, <string-name><surname>Heidari Khoei</surname> <given-names>H</given-names></string-name>, <string-name><surname>Hassanpour</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ghanaei</surname> <given-names>H</given-names></string-name>, <string-name><surname>Golestanfar</surname> <given-names>A</given-names></string-name>, <string-name><surname>Mehraban</surname> <given-names>H</given-names></string-name>, <etal>et al.</etal>, <article-title>Peroxisome proliferator-activated receptors (PPAR&#x03B1;, PPAR&#x03B3; and PPAR&#x03B2;/&#x03B4;) gene expression profile on ram spermatozoa and their relation to the sperm motility</article-title>. <source>Vet Res Forum</source>. <year>2016</year>; <volume>7</volume>: <fpage>27</fpage>&#x2013;<lpage>34</lpage>.</mixed-citation></ref>
<ref id="c77"><label>77.</label><mixed-citation publication-type="other"><string-name><surname>Maan</surname> <given-names>M</given-names></string-name>, <string-name><surname>Peters</surname> <given-names>JM</given-names></string-name>2, <article-title>Dutta M3, Patterson AD. Lipid metabolism and lipophagy in cancer</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2018</year>; <fpage>10</fpage>, pii: S0006-291X(18)30326-7.</mixed-citation></ref>
<ref id="c78"><label>78.</label><mixed-citation publication-type="journal"><string-name><surname>Tirinato</surname> <given-names>L</given-names></string-name>, <string-name><surname>Pagliari</surname> <given-names>F</given-names></string-name>, <string-name><surname>Limongi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Marini</surname> <given-names>M</given-names></string-name>, <string-name><surname>Falqui</surname> <given-names>A</given-names></string-name>, <string-name><surname>Seco</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal>, <article-title>An Overview of Lipid Droplets in Cancer and Cancer Stem Cells</article-title>. <source>Stem Cells Int</source>. <year>2017</year>:<fpage>1656053</fpage>.</mixed-citation></ref>
<ref id="c79"><label>79.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>F</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Ren</surname> <given-names>X</given-names></string-name>, <string-name><surname>Tian</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Wang, Liu</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal>, <article-title>Hormone-sensitive lipase deficiency alters gene expression and cholesterol content of mousetestis</article-title>. <source>Reproduction</source>. <year>2017</year>; <volume>2</volume>:<fpage>175</fpage>&#x2013;<lpage>185</lpage>.</mixed-citation></ref>
<ref id="c80"><label>80.</label><mixed-citation publication-type="journal"><string-name><surname>Christian</surname> <given-names>P</given-names></string-name>, <string-name><surname>Sacco</surname> <given-names>J</given-names></string-name>, <string-name><surname>Adeli</surname> <given-names>K</given-names></string-name>. <article-title>Autophagy: Emerging roles in lipid homeostasis and metabolic control</article-title>. <source>Biochim Biophys Acta</source>. <year>2013</year>; <volume>1831</volume>: <fpage>819</fpage>&#x2013;<lpage>824</lpage>.</mixed-citation></ref>
<ref id="c81"><label>81.</label><mixed-citation publication-type="journal"><string-name><surname>Yang</surname> <given-names>M</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ren</surname> <given-names>J</given-names></string-name>. <article-title>Autophagic Regulation of Lipid Homeostasis in Cardiometabolic Syndrome</article-title>. <source>Front Cardiovasc Med</source>. <year>2018</year>; <volume>3</volume>: <fpage>38</fpage>.</mixed-citation></ref>
<ref id="c82"><label>82.</label><mixed-citation publication-type="journal"><string-name><surname>Ma</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>YC</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>SQ</given-names></string-name>, <string-name><surname>Ping</surname> <given-names>P</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>XF</given-names></string-name>. <article-title>Lipophagy Contributes to Testosterone Biosynthesis in Male Rat Leydig Cells</article-title>. <source>Endocrinology.</source> <year>2018</year>; <volume>2</volume>: <fpage>1119</fpage>&#x2013;<lpage>1129</lpage>.</mixed-citation></ref>
<ref id="c83"><label>83.</label><mixed-citation publication-type="journal"><string-name><surname>Maizlin</surname> <given-names>ZV</given-names></string-name>, <string-name><surname>Belenky</surname> <given-names>A</given-names></string-name>, <string-name><surname>Kunichezky</surname> <given-names>M</given-names></string-name>, <string-name><surname>Sandbank</surname> <given-names>J</given-names></string-name>, <string-name><surname>Strauss</surname> <given-names>S</given-names></string-name>. <article-title>Leydig cell tumors of the testis: gray scale and color Doppler sonographic appearance</article-title>. <source>J Ultrasound Med.</source> <year>2004</year>; <volume>23</volume>: <fpage>959</fpage>&#x2013;<lpage>964</lpage>.</mixed-citation></ref>
<ref id="c84"><label>84.</label><mixed-citation publication-type="journal"><string-name><surname>Ishii</surname> <given-names>T</given-names></string-name>, <string-name><surname>Fukuzawa</surname> <given-names>R</given-names></string-name>, <string-name><surname>Sato</surname> <given-names>T</given-names></string-name>, <string-name><surname>Muroya</surname> <given-names>K</given-names></string-name>, <string-name><surname>Adachi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ihara</surname> <given-names>K</given-names></string-name>, <etal>et al.</etal>, <article-title>Gonadal macrophage infiltration in congenital lipoid adrenal hyperplasia</article-title>. <source>Eur J Endocrinol</source>. <year>2016</year>; <volume>175</volume>: <fpage>127</fpage>&#x2013;<lpage>132</lpage>.</mixed-citation></ref>
<ref id="c85"><label>85.</label><mixed-citation publication-type="journal"><string-name><surname>Chung</surname> <given-names>JY</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>H</given-names></string-name>, <string-name><surname>Midzak</surname> <given-names>A</given-names></string-name>, <string-name><surname>Burnett</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Papadopoulos</surname> <given-names>V</given-names></string-name>, <string-name><surname>Zirkin</surname> <given-names>BR</given-names></string-name>. <article-title>Drug ligand-induced activation of translocator protein (TSPO) stimulates steroid production by aged brown Norway rat Leydig cells</article-title>. <source>Endocrinology.</source> <year>2013</year>; <volume>154</volume>: <fpage>2156</fpage>&#x2013;<lpage>2165</lpage>.</mixed-citation></ref>
<ref id="c86"><label>86.</label><mixed-citation publication-type="journal"><string-name><surname>Albert</surname> <given-names>DH</given-names></string-name>, <string-name><surname>Ascoli</surname> <given-names>M</given-names></string-name>, <string-name><surname>Puett</surname> <given-names>D</given-names></string-name>, <string-name><surname>Coniglio</surname> <given-names>JG</given-names></string-name>. <article-title>Lipid composition and gonadotropin-mediated lipid metabolism of the M5480 murine Leydig celltumor</article-title>. <source>J Lipid Res.</source> <year>1980</year>; <volume>21</volume>: <fpage>862</fpage>&#x2013;<lpage>867</lpage>.</mixed-citation></ref>
<ref id="c87"><label>87.</label><mixed-citation publication-type="journal"><string-name><surname>Morrish</surname> <given-names>DW</given-names></string-name>, <string-name><surname>Venner</surname> <given-names>PM</given-names></string-name>, <string-name><surname>Siy</surname> <given-names>O</given-names></string-name>, <string-name><surname>Barron</surname> <given-names>G</given-names></string-name>, <string-name><surname>Bhardwaj</surname> <given-names>D</given-names></string-name>, <string-name><surname>Outhet</surname> <given-names>D</given-names></string-name>. <article-title>Mechanisms of endocrine dysfunction in patients with testicular cancer</article-title>. <source>J Natl Cancer Inst.</source> <year>1990</year>; <volume>82</volume>: <fpage>412</fpage>&#x2013;<lpage>418</lpage>.</mixed-citation></ref>
<ref id="c88"><label>88.</label><mixed-citation publication-type="journal"><string-name><surname>Manna</surname> <given-names>PR</given-names></string-name>, <string-name><surname>Jo</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Stocco</surname> <given-names>DM</given-names></string-name>. <article-title>Regulation of Leydig cell steroidogenesis by extracellular signal-regulated kinase 1/2: role of protein kinase A and protein kinase C signaling</article-title>. <source>J Endocrinol.</source> <year>2007</year>; <volume>193</volume>: <fpage>53</fpage>&#x2013;<lpage>63</lpage>.</mixed-citation></ref>
<ref id="c89"><label>89.</label><mixed-citation publication-type="journal"><string-name><surname>Moyle</surname> <given-names>WR</given-names></string-name>, <string-name><surname>Moudgal</surname> <given-names>NR</given-names></string-name>, <string-name><surname>Greep</surname> <given-names>RO</given-names></string-name>. <article-title>Cessation of steroidogenesis in Leydig cell tumors after removal of luteinizing hormone and adenosine cyclic 3',5'-monophosphate</article-title>. <source>J Biol Chem.</source> <year>1971</year>; <volume>16</volume>: <fpage>4978</fpage>&#x2013;<lpage>4982</lpage>.</mixed-citation></ref>
<ref id="c90"><label>90.</label><mixed-citation publication-type="journal"><string-name><surname>Basharat</surname> <given-names>P</given-names></string-name>, <string-name><surname>Arash</surname> <given-names>H</given-names></string-name>, <string-name><surname>Lahouti</surname> <given-names>AH</given-names></string-name>, <string-name><surname>Paik</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Albayda</surname> <given-names>J</given-names></string-name>, <string-name><surname>Pinal-Fernandez</surname> <given-names>I</given-names></string-name>, <etal>et al.</etal>, <article-title>Statin-induced Anti-HMGCR-associated Myopathy</article-title>. <source>J Am Coll Cardiol</source>. <year>2016</year>; <volume>68</volume>: <fpage>234</fpage>&#x2013;<lpage>235</lpage>.</mixed-citation></ref>
<ref id="c91"><label>91.</label><mixed-citation publication-type="journal"><string-name><surname>Baba</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Funakoshi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Mori</surname> <given-names>M</given-names></string-name>, <string-name><surname>Emoto</surname> <given-names>K</given-names></string-name>, <string-name><surname>Masugi</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ekmekcioglu</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal>, <article-title>Expression of monoacylglycerol lipase as a marker of tumour invasion and progression in malignant melanoma</article-title>. <source>J Eur Acad Dermatol Venereol</source>. <year>2017</year>; <volume>31</volume>: <fpage>2038</fpage>&#x2013;<lpage>2045</lpage>.</mixed-citation></ref>
<ref id="c92"><label>92.</label><mixed-citation publication-type="journal"><string-name><surname>Hanahan</surname> <given-names>D</given-names></string-name>, <string-name><surname>Weinberg</surname> <given-names>RA</given-names></string-name>. <article-title>Hallmarks of cancer: the next generation</article-title>. <source>Cell</source>. <year>2011</year>; <volume>144</volume>: <fpage>646</fpage>&#x2013;<lpage>674</lpage>.</mixed-citation></ref>
<ref id="c93"><label>93.</label><mixed-citation publication-type="journal"><string-name><surname>Yamaguchi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Fujikawa</surname> <given-names>N</given-names></string-name>, <string-name><surname>Nimura</surname> <given-names>S</given-names></string-name>, <string-name><surname>Tokuoka</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Tsuda</surname> <given-names>S</given-names></string-name>, <string-name><surname>Aiuchi</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal>, <article-title>Characterization of lipid droplets in steroidogenic MLTC-1 Leydig cells: Protein profiles and the morphological change induced by hormone stimulation</article-title>. <source>Biochim Biophys Acta</source>. <year>2015</year>; <volume>1851</volume>: <fpage>1285</fpage>&#x2013;<lpage>1295</lpage>.</mixed-citation></ref>
<ref id="c94"><label>94.</label><mixed-citation publication-type="journal"><string-name><surname>Shen</surname> <given-names>WJ</given-names></string-name>, <string-name><surname>Azhar</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kraemer</surname> <given-names>FB</given-names></string-name>. <article-title>Lipid droplets and steroidogenic cells</article-title>. <source>Exp Cell Res.</source> <year>2016</year>; <volume>15</volume>: <fpage>209</fpage>&#x2013;<lpage>214</lpage>.</mixed-citation></ref>
<ref id="c95"><label>95.</label><mixed-citation publication-type="journal"><string-name><surname>Lukyanenko</surname> <given-names>YO</given-names></string-name>, <string-name><surname>Carpenter</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Brigham</surname> <given-names>DE</given-names></string-name>, <string-name><surname>Stocco</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Hutson</surname> <given-names>JC</given-names></string-name>. <article-title>Regulation of Leydig cells through a steroidogenic acute regulatory protein-independent pathwayby a lipophilic factor from macrophages</article-title>. <source>J Endocrinol.</source> <year>1998</year>; <volume>158</volume>: <fpage>267</fpage>&#x2013;<lpage>275</lpage></mixed-citation></ref>
<ref id="c96"><label>96.</label><mixed-citation publication-type="journal"><string-name><surname>Allen</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Shankara</surname> <given-names>T</given-names></string-name>, <string-name><surname>Janus</surname> <given-names>P</given-names></string-name>, <string-name><surname>Buck</surname> <given-names>S</given-names></string-name>, <string-name><surname>Diemer</surname> <given-names>T</given-names></string-name>, <string-name><surname>Hales</surname> <given-names>KH</given-names></string-name>, <etal>et al.</etal>, <article-title>Energized, polarized, and actively respiring mitochondria are required for acute Leydig cellsteroidogenesis</article-title>. <source>Endocrinology</source>. <year>2006</year>; <volume>147</volume>: <fpage>3924</fpage>&#x2013;<lpage>3935</lpage>.</mixed-citation></ref>
<ref id="c97"><label>97.</label><mixed-citation publication-type="journal"><string-name><surname>Barbosa</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Siniossoglou</surname> <given-names>S</given-names></string-name>. <article-title>Function of lipid droplet-organelle interactions in lipid homeostasis</article-title>. <source>Biochim Biophys Acta.</source> <year>2017</year>; <volume>1864</volume>: <fpage>1459</fpage>&#x2013;<lpage>1468</lpage>.</mixed-citation></ref>
<ref id="c98"><label>98.</label><mixed-citation publication-type="journal"><string-name><surname>Schulze</surname> <given-names>A</given-names></string-name>, <string-name><surname>Harris</surname> <given-names>AL</given-names></string-name>. <article-title>How cancer metabolism is tuned for proliferation and vulnerable to disruption</article-title>. <source>Nature.</source> <year>2012</year>; <volume>491</volume>: <fpage>364</fpage>&#x2013;<lpage>73</lpage>.</mixed-citation></ref>
<ref id="c99"><label>99.</label><mixed-citation publication-type="journal"><string-name><surname>Baenke</surname> <given-names>F</given-names></string-name>, <string-name><surname>Peck</surname> <given-names>B</given-names></string-name>, <string-name><surname>Miess</surname> <given-names>H</given-names></string-name>, <string-name><surname>Schulze</surname> <given-names>A</given-names></string-name>. <article-title>Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development</article-title>. <source>Dis Model Mech</source>. <year>2013</year>; <volume>6</volume>: <fpage>1353</fpage>&#x2013;<lpage>1363</lpage>.</mixed-citation></ref>
<ref id="c100"><label>100.</label><mixed-citation publication-type="journal"><string-name><surname>Luo</surname> <given-names>X</given-names></string-name>, <string-name><surname>Cheng</surname> <given-names>C</given-names></string-name>, <string-name><surname>Tan</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Li</surname> <given-names>N</given-names></string-name>, <string-name><surname>Tang</surname> <given-names>M</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal>, <article-title>Emerging roles of lipid metabolism in cancer metastasis</article-title>. <source>Mol Cancer</source>. <year>2017</year>; <volume>16</volume>: <fpage>76</fpage>.</mixed-citation></ref>
<ref id="c101"><label>101.</label><mixed-citation publication-type="other"><string-name><surname>Barrera</surname> <given-names>G</given-names></string-name>. <article-title>Oxidative stress and lipid peroxidation products in cancer progression and therapy</article-title>. <source>ISRN Oncol</source>. <year>2012</year>; <fpage>137289</fpage>.</mixed-citation></ref>
<ref id="c102"><label>102.</label><mixed-citation publication-type="journal"><string-name><surname>Mostaghel</surname> <given-names>EA</given-names></string-name>, <string-name><surname>Nelson</surname> <given-names>PS</given-names></string-name>. <article-title>Intracrine androgen metabolism in prostate cancer progression: mechanisms of castration resistance and therapeutic implications</article-title>. <source>Best Pract Res Clin Endocrinol Metab</source>. <year>2008</year>; <volume>22</volume>: <fpage>243</fpage>&#x2013;<lpage>258</lpage>.</mixed-citation></ref>
<ref id="c103"><label>103.</label><mixed-citation publication-type="other"><string-name><surname>Bao</surname> <given-names>J</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Su</surname> <given-names>J</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>M</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>W</given-names></string-name>. <article-title>SREBP-1 is an independent prognostic marker and promotes invasion and migration in breast cancer</article-title>. <source>Oncol Lett. 2016; 12: 2409&#x2013;</source> <year>2416</year>.</mixed-citation></ref>
<ref id="c104"><label>104.</label><mixed-citation publication-type="journal"><string-name><surname>Beloribi-Djefaflia</surname> <given-names>S</given-names></string-name>, <string-name><surname>Vasseur</surname> <given-names>S</given-names></string-name>, <string-name><surname>Guillaumond</surname> <given-names>F</given-names></string-name>. <article-title>Lipid metabolic reprogramming in cancer cells</article-title>. <source>Oncogenesis</source>. <year>2016</year>; <volume>25</volume>, <fpage>e189</fpage>.</mixed-citation></ref>
<ref id="c105"><label>105.</label><mixed-citation publication-type="journal"><string-name><surname>Follo</surname> <given-names>MY</given-names></string-name>, <string-name><surname>Manzoli</surname> <given-names>L</given-names></string-name>, <string-name><surname>Poli</surname> <given-names>A</given-names></string-name>, <string-name><surname>McCubrey</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Cocco</surname> <given-names>L</given-names></string-name>. <article-title>PLC and PI3K/Akt/mTOR signalling in disease and cancer</article-title>. <source>Adv Biol Regul.</source> <year>2015</year>; <volume>57</volume>: <fpage>10</fpage>&#x2013;<lpage>16</lpage>.</mixed-citation></ref>
<ref id="c106"><label>106.</label><mixed-citation publication-type="journal"><string-name><surname>Oliveira</surname> <given-names>PF</given-names></string-name>, <string-name><surname>Cheng</surname> <given-names>CY</given-names></string-name>, <string-name><surname>Alves</surname> <given-names>MG</given-names></string-name>. <article-title>Emerging Role for Mammalian Target of Rapamycin in Male Fertility</article-title>. <source>Trends Endocrinol Metab.</source> <year>2017</year>; <volume>28</volume>: <fpage>165</fpage>&#x2013;<lpage>167</lpage>.</mixed-citation></ref>
<ref id="c107"><label>107.</label><mixed-citation publication-type="journal"><string-name><surname>Mendoza</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Er</surname> <given-names>EE</given-names></string-name>, <string-name><surname>Blenis</surname> <given-names>J</given-names></string-name>. <article-title>The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation</article-title>. <source>Trends Biochem Sci.</source> <year>2011</year>; <volume>36</volume>: <fpage>320</fpage>&#x2013;<lpage>328</lpage>.</mixed-citation></ref>
<ref id="c108"><label>108.</label><mixed-citation publication-type="journal"><string-name><surname>Schwarz</surname> <given-names>KRL</given-names></string-name>, <string-name><surname>de Castro</surname> <given-names>FC</given-names></string-name>, <string-name><surname>Schefer</surname> <given-names>L</given-names></string-name>, <string-name><surname>Botigelli</surname> <given-names>RC</given-names></string-name>, <string-name><surname>Paschoal</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Fernandes</surname> <given-names>H</given-names></string-name>, <etal>et al.</etal>, <article-title>The role of cGMP as a mediator of lipolysis in bovine oocytes and its effects on embryo development and cryopreservation</article-title>. <source>PLoS One</source> <year>2018</year>; <volume>13</volume>: <fpage>e0191023</fpage>.</mixed-citation></ref>
<ref id="c109"><label>109.</label><mixed-citation publication-type="journal"><string-name><surname>Ding</surname> <given-names>J</given-names></string-name>, <string-name><surname>Jiang</surname> <given-names>D</given-names></string-name>, <string-name><surname>Kurczy</surname> <given-names>M</given-names></string-name>, <string-name><surname>Nalepka</surname> <given-names>J</given-names></string-name>, <string-name><surname>Dudley</surname> <given-names>B</given-names></string-name>, <string-name><surname>Merkel</surname> <given-names>EI</given-names></string-name>, <etal>et al.</etal>, <article-title>Inhibition of HMG CoA reductase reveals an unexpected role for cholesterol during PGC migration in the mouse</article-title>. <source>BMC Dev Biol</source>. <year>2008</year>; <volume>31</volume>: <fpage>120</fpage>.</mixed-citation></ref>
<ref id="c110"><label>110.</label><mixed-citation publication-type="journal"><string-name><surname>Audagnotto</surname> <given-names>M</given-names></string-name>, <string-name><surname>Del Peraro</surname> <given-names>M</given-names></string-name>. <article-title>Protein post-translational modifications: In silico prediction tools and molecular modeling</article-title>. <source>Comput Struct Biotechnol J</source>. <year>2017</year>; <volume>15</volume>: <fpage>307</fpage>&#x2013;<lpage>319</lpage>.</mixed-citation></ref>
</ref-list>
</back>
</article>